Share
array:23 [ "pii" => "S0300289624001443" "issn" => "03002896" "doi" => "10.1016/j.arbres.2024.04.030" "estado" => "S300" "fechaPublicacion" => "2024-10-01" "aid" => "3561" "copyright" => "SEPAR" "copyrightAnyo" => "2024" "documento" => "article" "crossmark" => 1 "subdocumento" => "rev" "cita" => "Arch Bronconeumol. 2024;60 Supl 2:S46-S58" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:18 [ "pii" => "S0300289624002679" "issn" => "03002896" "doi" => "10.1016/j.arbres.2024.06.021" "estado" => "S300" "fechaPublicacion" => "2024-10-01" "aid" => "3621" "copyright" => "SEPAR" "documento" => "article" "crossmark" => 1 "subdocumento" => "rev" "cita" => "Arch Bronconeumol. 2024;60 Supl 2:S59-S66" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review Article</span>" "titulo" => "NRF2 Signaling Pathway in Chemo/Radio/Immuno-Therapy Resistance of Lung Cancer: Looking Beyond the Tip of the Iceberg" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "S59" "paginaFinal" => "S66" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2156 "Ancho" => 2333 "Tamanyo" => 542431 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">NRF2 signaling pathway: under basal condition, KEAP1 controlled NRF2 undergoes Cul3 mediated ubiquitination, leading to the proteosomal degradation of NRF2. Under oxidative stress, the NRF2 dissociates from KEAP1 and enters the nucleus where it heterodimerises with the sMaf proteins and regulates the ARE driven gene expression.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Sri Vidya Ramisetti, Tapas Patra, Vinayak Munirathnam, Jyothi Venkat Sainath, Durgadevi Veeraiyan, Akhileshwar Namani" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Sri Vidya" "apellidos" => "Ramisetti" ] 1 => array:2 [ "nombre" => "Tapas" "apellidos" => "Patra" ] 2 => array:2 [ "nombre" => "Vinayak" "apellidos" => "Munirathnam" ] 3 => array:2 [ "nombre" => "Jyothi Venkat" "apellidos" => "Sainath" ] 4 => array:2 [ "nombre" => "Durgadevi" "apellidos" => "Veeraiyan" ] 5 => array:2 [ "nombre" => "Akhileshwar" "apellidos" => "Namani" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289624002679?idApp=UINPBA00003Z" "url" => "/03002896/00000060000000S2/v1_202410311119/S0300289624002679/v1_202410311119/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0300289624002680" "issn" => "03002896" "doi" => "10.1016/j.arbres.2024.07.006" "estado" => "S300" "fechaPublicacion" => "2024-10-01" "aid" => "3622" "copyright" => "The Author(s)" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Arch Bronconeumol. 2024;60 Supl 2:S38-S45" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Analysis of Diagnostic Delay and its Impact on Lung Cancer Survival: Results From the Spanish Thoracic Tumor Registry" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "S38" "paginaFinal" => "S45" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 1 "multimedia" => array:5 [ "identificador" => "fig0015" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => false "mostrarDisplay" => true "figura" => array:1 [ 0 => array:4 [ "imagen" => "fx1.jpeg" "Alto" => 886 "Ancho" => 1790 "Tamanyo" => 238639 ] ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Cristina Candal-Pedreira, Alberto Ruano-Ravina, Virginia Calvo de Juan, Manuel Cobo, Alexandra Cantero, Delvys Rodríguez-Abreu, Anna Estival, Enric Carcereny, Ainhoa Hernandez, Rafael López Castro, Andrea Medina, Rosario García Campelo, Manuel Fernández Bruno, Reyes Barnabé, Joaquim Bosch-Barrera, Bartomeu Massutí, Manuel Dómine, Carlos Camps, Ana Laura Ortega, Mariano Provencio" "autores" => array:20 [ 0 => array:2 [ "nombre" => "Cristina" "apellidos" => "Candal-Pedreira" ] 1 => array:2 [ "nombre" => "Alberto" "apellidos" => "Ruano-Ravina" ] 2 => array:2 [ "nombre" => "Virginia" "apellidos" => "Calvo de Juan" ] 3 => array:2 [ "nombre" => "Manuel" "apellidos" => "Cobo" ] 4 => array:2 [ "nombre" => "Alexandra" "apellidos" => "Cantero" ] 5 => array:2 [ "nombre" => "Delvys" "apellidos" => "Rodríguez-Abreu" ] 6 => array:2 [ "nombre" => "Anna" "apellidos" => "Estival" ] 7 => array:2 [ "nombre" => "Enric" "apellidos" => "Carcereny" ] 8 => array:2 [ "nombre" => "Ainhoa" "apellidos" => "Hernandez" ] 9 => array:2 [ "nombre" => "Rafael" "apellidos" => "López Castro" ] 10 => array:2 [ "nombre" => "Andrea" "apellidos" => "Medina" ] 11 => array:2 [ "nombre" => "Rosario" "apellidos" => "García Campelo" ] 12 => array:2 [ "nombre" => "Manuel" "apellidos" => "Fernández Bruno" ] 13 => array:2 [ "nombre" => "Reyes" "apellidos" => "Barnabé" ] 14 => array:2 [ "nombre" => "Joaquim" "apellidos" => "Bosch-Barrera" ] 15 => array:2 [ "nombre" => "Bartomeu" "apellidos" => "Massutí" ] 16 => array:2 [ "nombre" => "Manuel" "apellidos" => "Dómine" ] 17 => array:2 [ "nombre" => "Carlos" "apellidos" => "Camps" ] 18 => array:2 [ "nombre" => "Ana Laura" "apellidos" => "Ortega" ] 19 => array:2 [ "nombre" => "Mariano" "apellidos" => "Provencio" ] ] ] ] "resumen" => array:1 [ 0 => array:3 [ "titulo" => "Graphical abstract" "clase" => "graphical" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0065" class="elsevierStyleSimplePara elsevierViewall"><elsevierMultimedia ident="fig0015"></elsevierMultimedia></p></span>" ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289624002680?idApp=UINPBA00003Z" "url" => "/03002896/00000060000000S2/v1_202410311119/S0300289624002680/v1_202410311119/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review Article</span>" "titulo" => "A Critical Review on the Role of Probiotics in Lung Cancer Biology and Prognosis" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "S46" "paginaFinal" => "S58" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Sumel Ashique, Neeraj Mishra, Ashish Garg, Nitish Kumar, Zuber Khan, Sourav Mohanto, Dinesh Kumar Chellappan, Arshad Farid, Farzad Taghizadeh-Hesary" "autores" => array:9 [ 0 => array:4 [ "nombre" => "Sumel" "apellidos" => "Ashique" "email" => array:1 [ 0 => "ashiquesumel007@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Neeraj" "apellidos" => "Mishra" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Ashish" "apellidos" => "Garg" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "Nitish" "apellidos" => "Kumar" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 4 => array:3 [ "nombre" => "Zuber" "apellidos" => "Khan" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 5 => array:3 [ "nombre" => "Sourav" "apellidos" => "Mohanto" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] ] ] 6 => array:3 [ "nombre" => "Dinesh Kumar" "apellidos" => "Chellappan" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] ] ] 7 => array:3 [ "nombre" => "Arshad" "apellidos" => "Farid" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">h</span>" "identificador" => "aff0040" ] ] ] 8 => array:4 [ "nombre" => "Farzad" "apellidos" => "Taghizadeh-Hesary" "email" => array:2 [ 0 => "Farzadth89@gmail.com" 1 => "taghizadeh_hesary.f@iums.ac.ir" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">i</span>" "identificador" => "aff0045" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">j</span>" "identificador" => "aff0050" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:10 [ 0 => array:3 [ "entidad" => "Department of Pharmaceutical Sciences, Bengal College of Pharmaceutical Sciences & Research, Durgapur 713212, West Bengal, India" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior 474005, MP, India" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Guru Ramdas Khalsa Institute of Science and Technology, Pharmacy, Jabalpur, MP 483001, India" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "SRM Modinagar College of Pharmacy, SRM Institute of Science and Technology (Deemed to be University), Delhi-NCR Campus, Modinagar, Ghaziabad, Uttar Pradesh 201204, India" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Division of Neuroscience, Department of Pharmacology, ISF College of Pharmacy, Moga, Punjab, India" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Department of Pharmaceutics, Yenepoya Pharmacy College & Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka 575018, India" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia" "etiqueta" => "g" "identificador" => "aff0035" ] 7 => array:3 [ "entidad" => "Gomal Center of Biochemistry and Biotechnology, Gomal University, Dera Ismail Khan 29050, Pakistan" "etiqueta" => "h" "identificador" => "aff0040" ] 8 => array:3 [ "entidad" => "ENT and Head and Neck Research Center and Department, The Five Senses Health Institute, School of Medicine, Iran University of Medical Sciences, Tehran, Iran" "etiqueta" => "i" "identificador" => "aff0045" ] 9 => array:3 [ "entidad" => "Department of Clinical Oncology, Iran University of Medical Sciences, Tehran, Iran" "etiqueta" => "j" "identificador" => "aff0050" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding authors." ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2146 "Ancho" => 2333 "Tamanyo" => 512756 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">The function of the microbiome in lung cancer. Schematic illustration of lung microbiota to maintain homeostasis and cancer development. In the biology of lung cancer, the microbiota plays a number of functions and employs a range of techniques. The protagonists of the tumor microenvironment are bacteria found in the lungs and upper respiratory system, as well as those with intra-tumor and intracellular locations. The gut microbiota is crucial in influencing how the immune system reacts and how inflamed the body is. This is in addition to the bacteria involved in bloodstream translocation events. It's also possible that certain bacterial toxins with the potential to activate oncogenic pathways might alter lung function. Additionally, cigarette smoke and pollution are the two main causes of the dysbiotic changes in the lungs. Finally, the microbiome may affect metastatic pathways by increasing the production of vascular endothelial growth factors and promoting inflammation.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Recent studies have suggested that lung cancer ranks as the second highest cause of mortality worldwide.<a class="elsevierStyleCrossRef" href="#bib0740"><span class="elsevierStyleSup">1</span></a> Several authors have established that smoking accounts for over 90% of lung cancer incidences. In addition, air pollution and several other respiratory toxins are being recognized as important risk factors for lung carcinogenesis. There are several factors that largely influence the pathological condition of a disease, namely, the influx of bacterial colonies, immunological removal of such colonies, adaptability of the bacterial strains to host threat, and the capability of such microbes to reproduce under specific environmental conditions. Although the health of individuals with early-stage lung cancer has significantly improved during the past few decades, the total 5-year survival rate is reported to be just over 9% for males and 15% for women, despite developments and numerous treatment advancements.<a class="elsevierStyleCrossRef" href="#bib0745"><span class="elsevierStyleSup">2</span></a> Hence, innovative and advanced approaches are needed to prevent and treat lung cancer.<a class="elsevierStyleCrossRef" href="#bib0750"><span class="elsevierStyleSup">3</span></a> Available evidence has put forward that except for tobacco smoking, which is a well-known risk factor for lung cancer, several other risk factors can be involved, including genetic factors, infections (HPV, HIV, and EBV), previous lung disease (<span class="elsevierStyleItalic">e.g.</span>, chronic obstructive pulmonary disease, tuberculosis), air pollution, radon or asbestos exposure, improper diet, marijuana smoking, and alcohol consumption.<a class="elsevierStyleCrossRef" href="#bib0755"><span class="elsevierStyleSup">4</span></a> However, there are cases with lung cancer who have never smoked and do not have the aforementioned risk factors. This issue has sparked curiosity among researchers worldwide to explore other factors involved in the pathogenesis of lung cancer.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Trillions of microorganisms have been reported to reside within the human gastrointestinal system, and the bacterial interplay between the microbiota and other body cells is crucial for preserving immunological homeostasis in the gut milieu.<a class="elsevierStyleCrossRefs" href="#bib0760"><span class="elsevierStyleSup">5–7</span></a> The World Health Organization (WHO) and the Food and Agriculture Organization (FAO) have defined <span class="elsevierStyleItalic">probiotics</span> as live microorganisms that bestow a favorable impact on human health when administered adequately.<a class="elsevierStyleCrossRefs" href="#bib0775"><span class="elsevierStyleSup">8,9</span></a> Potential nutritional and physiological benefits of gut microbiota include nutrient utilization, infection resistance, modification of gut microbial groups, immune reinforcement, and regulation of the host metabolism.<a class="elsevierStyleCrossRef" href="#bib0785"><span class="elsevierStyleSup">10</span></a> Probiotics that boost hosts’ health have garnered much attention recently. Clinical studies have revealed that probiotics can improve immune function and reduce the severity and incidence of lung diseases.<a class="elsevierStyleCrossRef" href="#bib0790"><span class="elsevierStyleSup">11</span></a> The idea of regulating immunomodulation and governing pulmonary homeostasis through healthy bacteria by gut–lung interaction is reinforced using beneficial probiotics.</p><p id="par0015" class="elsevierStylePara elsevierViewall">In conclusion, while lung cancer remains a formidable global health challenge with a low 5-year survival rate, the multifaceted nature of its development, involving various risk factors such as smoking, genetic predisposition, and environmental exposures, necessitates innovative approaches. Beyond traditional risk factors, the emerging field of research on the gut–lung interaction highlights the potential of probiotics in modulating immune function and influencing lung health, providing a promising avenue for further exploration and the development of novel strategies for lung cancer prevention and management.</p><p id="par0020" class="elsevierStylePara elsevierViewall">This review aims to comprehensively examine the role of probiotics in the development, progression, and treatment of lung cancer, with a specific focus on their impact through the gut–lung axis and immune modulation. We seek to explore the potential mechanisms by which probiotics may influence lung cancer biology, acknowledging the current gaps in understanding their precise mechanisms. Additionally, this review will identify key areas for future research, particularly the need for clinical trials that delineate the efficacy of specific probiotic strains, optimal dosages, and treatment durations. Recognizing the variability in individual responses to probiotics, the prospects for personalized probiotic therapies tailored to individual genetic backgrounds, microbiome compositions, and lifestyle factors will also be considered. Furthermore, the integration of probiotics with conventional lung cancer treatments, evaluating potential synergistic effects, safety concerns, and regulatory considerations will also be discussed. By doing so, this review aims to shed light on the promising yet complex role of probiotics in lung cancer management, setting the stage for future investigations that could lead to novel therapeutic strategies.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Methods</span><p id="par0025" class="elsevierStylePara elsevierViewall">The relevant literature was searched using Web of Science, PubMed, and Science Direct in English by December 2023. The databases were searched using the following keywords: “probiotics”; “microbiome”, “lung cancer”, “gut–lung axis”, “immune system” and their equivalent terms. Case reports, commentary, and Editorial papers were not included in this review.</p><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Gut–lung axis</span><p id="par0030" class="elsevierStylePara elsevierViewall">The gastrointestinal tract and the lungs share a common embryonic origin.<a class="elsevierStyleCrossRef" href="#bib0740"><span class="elsevierStyleSup">1</span></a> In addition, they can physically interact due to the possibility of ingested germs reaching the gastrointestinal and respiratory systems, as well as the ability of gastroesophageal contents to enter the lungs through inhalation.<a class="elsevierStyleCrossRef" href="#bib0795"><span class="elsevierStyleSup">12</span></a> The gut–lung axis (GLA) has been identified as playing a critical role in both health and disease, underpinned by the extensive interaction between gastrointestinal and pulmonary systems.<a class="elsevierStyleCrossRef" href="#bib0800"><span class="elsevierStyleSup">13</span></a> Similarities in the mucosa covering the stomach and lungs and those of the other organs that make up the mucosal immune system (MIS), foster comparable dynamics involving exchanges between the immune system and associated microbiota.<a class="elsevierStyleCrossRef" href="#bib0805"><span class="elsevierStyleSup">14</span></a> As a result of their indirect connections with the lymphatic and circulatory systems, the immune response also influences the scenario systematically; however, the extent of immunological reaction is mostly dependent on the location of the very first encounter.<a class="elsevierStyleCrossRef" href="#bib0810"><span class="elsevierStyleSup">15</span></a> Firmicutes and Bacteroidetes are the common bacterial phyla in the lungs and intestines of healthy humans. The overall microbial ecology is influenced by the interplay between lungs and intestines, partly because of nutrient interchange and antimicrobial bio-actives.<a class="elsevierStyleCrossRefs" href="#bib0815"><span class="elsevierStyleSup">16–18</span></a> The relationship between the microbial population of the lung and the gut is vague, and how the gut microbiota impacts the lungs, intestine, and other systems is a topic of further investigation.<a class="elsevierStyleCrossRef" href="#bib0830"><span class="elsevierStyleSup">19</span></a> Antigen-presenting cells (<span class="elsevierStyleItalic">e.g.</span>, dendritic cells), B cells, T cells (esp. <span class="elsevierStyleItalic">T</span><span class="elsevierStyleInf">reg</span> cells), and intestinal epithelial cells are among the most stimulated cells by microbial communities.<a class="elsevierStyleCrossRef" href="#bib0835"><span class="elsevierStyleSup">20</span></a> There have been several progressive studies explaining the molecular foundation of entero-pulmonary interactions. These studies have mainly reported on antimicrobial peptides (AMPs) and secretory IgA, as well as the formation of microbial metabolites like the kynurenine pathway.<a class="elsevierStyleCrossRef" href="#bib0840"><span class="elsevierStyleSup">21</span></a> The incidence of asthma, lung infections, and several other respiratory diseases have now been linked to dysbiosis.<a class="elsevierStyleCrossRef" href="#bib0845"><span class="elsevierStyleSup">22</span></a> Brown et al. revealed the physiological benefits of the gut microbiota.<a class="elsevierStyleCrossRef" href="#bib0850"><span class="elsevierStyleSup">23</span></a> Several gut microbiotas are involved in the synthesis of interleukins, like IL-17A, which is essential for the increased production of granulocyte-macrophage-stimulating factors in the lung. These factors activate the killing and elimination of potential macrophages in the lung alveoli.<a class="elsevierStyleCrossRef" href="#bib0855"><span class="elsevierStyleSup">24</span></a> Furthermore, lung microbiota modification causes both local and systemic immune alterations. These events may promote intestinal immune response, as seen in <span class="elsevierStyleItalic">Staphylococcus aureus</span>-induced pneumonia, resulting in sepsis and apoptotic events in the gut.<a class="elsevierStyleCrossRef" href="#bib0860"><span class="elsevierStyleSup">25</span></a></p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Lung microbiomes and host immunity</span><p id="par0035" class="elsevierStylePara elsevierViewall">The mucus layer in the intestine acts as a physical barrier that separates the luminal contents of the gut, including digested food and microorganisms, from the underlying epithelial cells of the intestinal lining. This barrier helps prevent direct contact between potentially harmful bacteria and the epithelium, which can trigger inflammatory responses or infections. The mucus layer also contains immunoglobulins, antimicrobial peptides, and other immune components that help defend against invading pathogens. Additionally, the mucus layer serves as a habitat for certain beneficial bacteria, which can compete with harmful bacteria for resources and space.<a class="elsevierStyleCrossRef" href="#bib0865"><span class="elsevierStyleSup">26</span></a> The recent identification of a novel CD4<span class="elsevierStyleSup">+</span> T cell subset known as Th17 has revolutionized the comprehension of the underlying causes of numerous chronic immune-mediated conditions. Particularly in regions of the body that interact closely with the microbial environment, such as the gastrointestinal and respiratory tracts, as well as the skin, where Th17 cells are predominantly found. When the immune response against self-components becomes dysregulated in these tissues, it can lead to the development of chronic inflammatory diseases.<a class="elsevierStyleCrossRef" href="#bib0870"><span class="elsevierStyleSup">27</span></a> By influencing the host's sensitivity to different pathogenic agents and therapeutic effects, the microbiota controls the host's immune functionality. The ability of hosts to detect and stop bacterial or fungal invasions and illnesses results from the dynamic interplay between the microbiota and the immune systems. Secretory IgA (SIgA) plays a vital role as the initial defense barrier safeguarding the intestinal epithelium against enteric toxins and pathogenic microorganisms. Through a process referred to as immune exclusion, SIgA actively contributes to the removal of antigens and pathogenic microorganisms from the intestinal lumen. It achieves this by obstructing their access to epithelial receptors, ensnaring them within the mucus layer, and facilitating their elimination through peristaltic and mucociliary activities.<a class="elsevierStyleCrossRef" href="#bib0875"><span class="elsevierStyleSup">28</span></a> In the human intestine, a stable state of equilibrium is upheld through precise regulation of microbial levels and the corresponding immune response. When this balance falters, it can lead to various pathological conditions. Toll-like receptors (TLRs), which are a part of the innate immune system, play a pivotal role as intermediaries connecting the intestinal epithelial barrier, the microbiota, and the immune system. The TLR pathway, which is typically activated in response to pathogens, contributes to the development of numerous infectious and inflammatory diseases.<a class="elsevierStyleCrossRef" href="#bib0880"><span class="elsevierStyleSup">29</span></a> Preclinical studies on germ-free mice have shown significant immunological abnormalities, including a compromised mucous layer, underlining the gut microbiota's role in immune homeostasis. This effect may be attributed to reduced immunoglobulin secretion.<a class="elsevierStyleCrossRefs" href="#bib0885"><span class="elsevierStyleSup">30,31</span></a> IgA reportedly controls bacterial pathogenicity in the stomach primarily by preventing bacterial adhesion to mucosal epithelial cells.<a class="elsevierStyleCrossRef" href="#bib0875"><span class="elsevierStyleSup">28</span></a> Interleukin 17 (IL-17) stands as a crucial proinflammatory cytokine within the T helper 17 (Th17) pathways. It plays a pivotal role in both the clearance of specific pathogens and the development of various inflammatory diseases. This cytokine, along with its counterpart IL-17F, is expressed by distinct types of T cells, particularly Th17 cells, as well as certain other lymphocytes. These cytokines are central players in regulating the immune response during host defense and in the context of various inflammatory disorders.<a class="elsevierStyleCrossRef" href="#bib0895"><span class="elsevierStyleSup">32</span></a> The delicate balance of commensal bacteria is more likely to be upset and exogenous pathogens are more likely to infect low-density micro-ecologies with unstable microbiomes.<a class="elsevierStyleCrossRef" href="#bib0900"><span class="elsevierStyleSup">33</span></a> High commensal microbiota density may improve the clinical effectiveness of vaccination in infants.<a class="elsevierStyleCrossRef" href="#bib0885"><span class="elsevierStyleSup">30</span></a> The clearance of certain pathogens is aided by IL-17, where the gut microbiota may control and boost Th17 responses.<a class="elsevierStyleCrossRefs" href="#bib0905"><span class="elsevierStyleSup">34,35</span></a> IL-17 pathway is associated with various diseases such as airway disease (asthma and obliterative bronchiolitis), sarcoidosis, and bone marrow transplant-related pneumonitis.<a class="elsevierStyleCrossRefs" href="#bib0785"><span class="elsevierStyleSup">10,36–38</span></a> Iida et al. reported that microbiota of lungs regulates gene expression of various inflammatory cytokines (IL-5, IL-10, and IFN). Furthermore, their experiments on lungs of neonatal mice showed programmed death ligand 1 (PD-L1) which was expressed at a higher level as compared to germ-free mice. There was also increase in the number of CD11b<span class="elsevierStyleSup">+</span>dendritic cells (DCs) and FoxP3<span class="elsevierStyleSup">+</span>CD25<span class="elsevierStyleSup">+</span>T<span class="elsevierStyleInf">reg</span> cells.<a class="elsevierStyleCrossRef" href="#bib0930"><span class="elsevierStyleSup">39</span></a> Steed et al. demonstrated that desaminotyrosine (DAT), a metabolite produced by <span class="elsevierStyleItalic">Clostridium orbiscindens</span>, defends the host from influenza by increasing the type I IFN signaling and thereby decreasing lung cancer pathogenesis.<a class="elsevierStyleCrossRef" href="#bib0935"><span class="elsevierStyleSup">40</span></a> Ichinohe et al.<a class="elsevierStyleCrossRef" href="#bib0940"><span class="elsevierStyleSup">41</span></a> also reported data showing that commensal microbiota might regulate immune responses in airway mucosa by inflammasomes and convey activation signals (immune signals) after influenza virus infection remains in a steady state. Inulin, a fermentable fiber, has been reported to change the composition of the gut microbiome and related metabolites, including short chain fatty acids. It is also found to promote resistance to influenza-virus infection <span class="elsevierStyleItalic">via</span> decreasing neutrophil-induced injury and promoting the antiviral CD8<span class="elsevierStyleSup">+</span> T cell responses in mice. Additionally, enriched lung microbiota due to oral microbiomes can be related to Th17 inflammation. The composition of the lung microbiota is shown to critically affect TLR4 responses.<a class="elsevierStyleCrossRef" href="#bib0860"><span class="elsevierStyleSup">25</span></a> Additionally, it has been demonstrated that the commensal microbiota promotes the growth and activation of Vg6<span class="elsevierStyleSup">+</span>Vd1<span class="elsevierStyleSup">+</span> T cells in lung cancer.<a class="elsevierStyleCrossRef" href="#bib0940"><span class="elsevierStyleSup">41</span></a> However, there is no universally accepted definition of a healthy or advantageous lung microbiome, in part because of our incomplete understanding of how the lung's resident microbiome and host immunity are related.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Lung microbiome and host metabolism</span><p id="par0040" class="elsevierStylePara elsevierViewall">Intestinal microbiome changes that deregulate the host metabolism have been thoroughly explored.<a class="elsevierStyleCrossRefs" href="#bib0945"><span class="elsevierStyleSup">42,43</span></a> According to reports, microbiome-derived carcinogens, including acetaldehyde and deoxycholic acid, are crucial in developing esophageal and liver cancers.<a class="elsevierStyleCrossRefs" href="#bib0955"><span class="elsevierStyleSup">44,45</span></a> Visconti et al. found metagenomic shotgun sequencing useful in the characterization of the gut microbiota while also analyzing the metabolites found in the blood and feces.<a class="elsevierStyleCrossRef" href="#bib0965"><span class="elsevierStyleSup">46</span></a> Their results confirmed an association between gut bacterial metabolic pathways and metabolites in blood and feces.<a class="elsevierStyleCrossRef" href="#bib0965"><span class="elsevierStyleSup">46</span></a> Through a variety of physiological processes, metabolism is crucial for preserving the homeostasis of the human body.<a class="elsevierStyleCrossRef" href="#bib0970"><span class="elsevierStyleSup">47</span></a> Additionally, a recent study was conducted to explore the association between host metabolism and the lung microbiome. Weinberg et al. showed that lung microbiota can modulate the phenotypes of lung cancer tumor microenvironment components and can regulate the metabolic and inflammatory pathways.<a class="elsevierStyleCrossRef" href="#bib0975"><span class="elsevierStyleSup">48</span></a> Given the importance of tumor microenvironment in cancer progression and treatment resistance,<a class="elsevierStyleCrossRef" href="#bib0980"><span class="elsevierStyleSup">49</span></a> this finding can be applied in future studies to modulate the cancer biology. Cribbs et al. found that the glycerophospholipid pathways play a crucial role in the development of pneumonia in patients with AIDS. This study led to the identification of specific metabolic profiles associated with bacterial taxonomic resolution through sequencing the 16S gene in the bronchoalveolar lavage.<a class="elsevierStyleCrossRef" href="#bib0985"><span class="elsevierStyleSup">50</span></a> In addition, <span class="elsevierStyleItalic">Pseudomonas aeruginosa</span>-based primary metabolites utilize substrates produced by other microbes, like <span class="elsevierStyleItalic">Rothia mucilaginosa</span>, which may take part in the etiology of cystic fibrosis.<a class="elsevierStyleCrossRef" href="#bib0990"><span class="elsevierStyleSup">51</span></a> One of the potent metabolites is SCFA, which is produced in large amounts by microbiota in the large intestine which acts as a major signaling biomolecule in host cells. Even though various research investigations have focused on the role of SCFA in the host gut and immunity, its effects on the respiratory system, epithelium, and immune system remain largely unknown. <span class="elsevierStyleItalic">S. aureus</span> is one of the bacteria that animals are more likely to encounter, which may be influenced by the pulmonary Th17 immunity.<a class="elsevierStyleCrossRef" href="#bib0995"><span class="elsevierStyleSup">52</span></a> Furthermore, several research findings have revealed that altering the gut microbiota in preclinical models may change the host immunity and delay response to infection.<a class="elsevierStyleCrossRef" href="#bib0940"><span class="elsevierStyleSup">41</span></a></p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Microbiota and lung cancer</span><p id="par0045" class="elsevierStylePara elsevierViewall">Recent research has elucidated the complex interplay between microbial communities, tumor development, and immune cell response in the context of cancer. They elucidated the molecular pathways involved in oncogenesis and their potential significance. However, recent literature has revealed a robust bidirectional link between gut dysbiosis and lung oncogenesis. It is well-known that microorganisms can initiate tumor progression, mainly by generating bacterio-toxins and other pro-inflammatory factors.<a class="elsevierStyleCrossRefs" href="#bib0740"><span class="elsevierStyleSup">1,53</span></a> Due to the large surface area of the mucosal site and the constant connection with the outside environment, the lung is vulnerable to diverse microbes and environmental pollutants.</p><p id="par0050" class="elsevierStylePara elsevierViewall">Lungs, for long, had been thought to be free from microbial contamination, but recent studies have revealed that they can be the home of a diverse commensal bacteria.<a class="elsevierStyleCrossRef" href="#bib1005"><span class="elsevierStyleSup">54</span></a> The growth of such microbes is initiated through numerous factors, such as the presence of new bacteria, mechanical and immunological clearance, and the capability of microbes to reproduce under particular environmental conditions<a class="elsevierStyleCrossRef" href="#bib1005"><span class="elsevierStyleSup">54</span></a> (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). Interestingly, these microbial populations appeared to be reduced in diseased conditions such as cystic fibrosis, chronic obstructive pulmonary disease, and cancer.<a class="elsevierStyleCrossRefs" href="#bib1010"><span class="elsevierStyleSup">55,56</span></a> This finding clearly indicates an underlying complementary physiological role of these microbiotas to protect the lungs from infections and boost our immune system. To date, limited research has been done on the lung microbiota than on the gastrointestinal tract.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0055" class="elsevierStylePara elsevierViewall">In a study conducted in non-smoking female patients with lung adenocarcinoma, a correlation was established between cancer stage and microbiota.<a class="elsevierStyleCrossRef" href="#bib1000"><span class="elsevierStyleSup">53</span></a> In addition, two correlations (positive and negative) were established. A positive correlation was established between one set of microbiotas (<span class="elsevierStyleItalic">Faecalibacterium as FB</span> and <span class="elsevierStyleItalic">T category</span>) and primary tumor size. In contrast, a negative correlation was established between other microbiota (<span class="elsevierStyleItalic">Fusicatenibacter saccharivorans</span> and <span class="elsevierStyleItalic">Bacteroides</span>) and tumor size. Epidermal growth factor receptor (EGFR)-wild-type patients have abundant <span class="elsevierStyleItalic">Bifidobacterium</span> and FB, whereas <span class="elsevierStyleItalic">Blautia</span> was relatively low compared to the EGFR-mutated population.<a class="elsevierStyleCrossRef" href="#bib1020"><span class="elsevierStyleSup">57</span></a> It is difficult to determine whether these changes had occurred before or after the development of cancer. It has been demonstrated that <span class="elsevierStyleItalic">Bacteroides</span> and <span class="elsevierStyleItalic">Faecalibacterium</span> can individually upregulate T-cells in the cancer lesion, followed by inhibiting proliferative cells and can activate <span class="elsevierStyleItalic">T</span><span class="elsevierStyleInf">reg</span> cells, respectively.<a class="elsevierStyleCrossRef" href="#bib1025"><span class="elsevierStyleSup">58</span></a> Thus, these microbiotas may play a significant role in targeted cancer treatment as their biochemical metabolites may adversely affect the immune system. A few Gram-negative bacteria (<span class="elsevierStyleItalic">Enterobacter</span>, <span class="elsevierStyleItalic">Haemophilus influenzae</span>, and <span class="elsevierStyleItalic">Escherichia coli</span>) are capable of colonizing lung cancer. Patients with lung cancer showed low levels of <span class="elsevierStyleItalic">Firmicutes</span> and <span class="elsevierStyleItalic">Proteobacteria</span> compared to healthy individuals, whereas healthy individuals exhibited high numbers of <span class="elsevierStyleItalic">Bacteroidetes</span> and <span class="elsevierStyleItalic">Firmicutes</span> bacteria.<a class="elsevierStyleCrossRef" href="#bib1030"><span class="elsevierStyleSup">59</span></a> These microbiotas persisted irrespective of how the bacteria in cancer evolved. Additionally, the gut microbiota and its metabolites trigger the toll-like receptor (TLR) response, which causes T lymphocytes to spread to distant areas when they pass through the epithelial barrier and enter the circulation.<a class="elsevierStyleCrossRef" href="#bib1035"><span class="elsevierStyleSup">60</span></a></p><p id="par0060" class="elsevierStylePara elsevierViewall">Studies have revealed a link between <span class="elsevierStyleItalic">Enterococcus hirae</span> and small cell lung cancer (SCLC) wherein bacteria were found to move from the gastrointestinal tract and enhance a tumor-specific response by activating TLR and subsequently triggered the formation of memory responses.<a class="elsevierStyleCrossRef" href="#bib1000"><span class="elsevierStyleSup">53</span></a> There is growing proof that the causes of inflammation and bacterial infections may encourage the intestinal microbiota's transition from mutualism to a pro-carcinogenic form. Innumerable bacteria have been extensively investigated in terms of their molecular mechanisms, and researchers have explored their potential as a novel approach to cancer treatment.<a class="elsevierStyleCrossRef" href="#bib1040"><span class="elsevierStyleSup">61</span></a> Within the realm of omics disciplines, proteomics plays a crucial role in the study of bacterial toxins. Advancements in proteomics have significantly improved the understanding of bacterial toxins, facilitating their characterization and contributing to the development of anti-cancer drugs based on these toxins.<a class="elsevierStyleCrossRef" href="#bib1045"><span class="elsevierStyleSup">62</span></a> Bacterial endotoxins, such as LPS, are capable of entering the bloodstream through a leaky gut and may trigger systemic inflammation, potentially affecting the lung microenvironment. They may promote inflammatory responses that could potentially contribute to lung cancer development or progression.<a class="elsevierStyleCrossRef" href="#bib1050"><span class="elsevierStyleSup">63</span></a> Altered gut microbiota composition has been linked to various diseases, including cancer. However, the specific gut microbiota profile in lung cancer patients has remained relatively unexplored. Zheng and colleagues conducted a study<a class="elsevierStyleCrossRef" href="#bib1055"><span class="elsevierStyleSup">64</span></a> where they discovered a significant shift in the composition of gut microbiota in individuals with lung cancer compared to healthy individuals. In this study, the researchers analyzed the gut microbiota composition in a discovery group consisting of 42 early-stage lung cancer patients and 65 healthy individuals using 16S ribosomal RNA (rRNA) gene sequencing analysis. Bacteria can produce enzyme-active proteins that alter host cells’ DNA or interact with determining cell signaling pathways regulating inflammation, cell proliferation, and apoptosis.<a class="elsevierStyleCrossRef" href="#bib1055"><span class="elsevierStyleSup">64</span></a> In prognostic studies, the lung microbiota's composition might be crucial. Identification and isolation of gut microbiota can be helpful for early-stage diagnosis of lung cancer.<a class="elsevierStyleCrossRef" href="#bib1060"><span class="elsevierStyleSup">65</span></a><span class="elsevierStyleItalic">Bacillus</span> spp., found in lung secretions, has been associated with a higher risk of lung cancer,<a class="elsevierStyleCrossRef" href="#bib1065"><span class="elsevierStyleSup">66</span></a> whereas the healthy group had greater levels of <span class="elsevierStyleItalic">Bifidobacterium</span> and <span class="elsevierStyleItalic">Faecalibacterium</span>. The microbiota in the sputum and stomach are dysbiotic. When considerable amounts of fiber are consumed, the concentration of short-chain fatty acids (SCFAs) increases in the blood, sputum, and stomach, indicating their entry into the lungs and airways.<a class="elsevierStyleCrossRef" href="#bib1070"><span class="elsevierStyleSup">67</span></a> Overall, these findings demonstrate that microbiota is essential for developing lung cancer. Modifying the immune system and addressing the local and distal microbiota are components of a promising innovative strategy for the prevention and treatment of lung cancer.<a class="elsevierStyleCrossRef" href="#bib1075"><span class="elsevierStyleSup">68</span></a></p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">The role of microbiota in specific lung cancers</span><p id="par0065" class="elsevierStylePara elsevierViewall">Immune cells in the lungs help to maintain homeostasis, making the lung an important location of immunological–microbiota interaction. Lung cancer and bacterial dysbiosis are related, according to growing evidence from research on humans and laboratory animals.<a class="elsevierStyleCrossRef" href="#bib0825"><span class="elsevierStyleSup">18</span></a> Lung cancer has been linked to decreased diversity, enrichment in particular genera of bacteria, and increased microbial colonies.<a class="elsevierStyleCrossRef" href="#bib1080"><span class="elsevierStyleSup">69</span></a> Chronic lung infection may be the primary cause of cancer when microbial dysbiosis creates more hypoxemia, a micro-environment that augments cancer proliferation.<a class="elsevierStyleCrossRef" href="#bib1085"><span class="elsevierStyleSup">70</span></a> The optional anaerobic characteristics of the bacteria that preferentially colonize tumors contribute to the observation that anaerobic respiration is increased in lung cancer. These microbiotas grow and worsen disease conditions by promoting and maintaining hypoxic conditions and establishing a pro-inflammatory tumor microenvironment.<a class="elsevierStyleCrossRef" href="#bib1090"><span class="elsevierStyleSup">71</span></a> Notably, Jin and colleagues reported an exciting finding. They attempted to establish a link between the abundance of microbiota present in airways (rather than GIT microbiota) and the number of tumors developed in the lungs.<a class="elsevierStyleCrossRef" href="#bib0920"><span class="elsevierStyleSup">37</span></a> They concluded that the local microbiota was substantially more important in the progression of lung carcinoma. Additionally, they showed that an intratracheally injected mixture of microbiota derived from developed lung malignancies significantly augmented tumor formation.<a class="elsevierStyleCrossRef" href="#bib0920"><span class="elsevierStyleSup">37</span></a></p><p id="par0070" class="elsevierStylePara elsevierViewall">There was no change in the beta diversity between the malignant lung tissues and healthy tissues. In contrast, patients with lung cancer have exhibited a reduction in alpha diversity of the microbiota tumor microenvironment as compared to the adjacent non-malignant lung tissues (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>).</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0075" class="elsevierStylePara elsevierViewall">Although there is no consensus on what makes for a healthy or sick lung microbiome, several researchers have discovered intriguing links between particular microbiota species (taxonomy or genera) and lung cancer. Jin and colleagues confirmed the significance of inter-immunity exchanges of the microbiota in supporting inflammation and the growth of lung cancer in a laboratory mice model.<a class="elsevierStyleCrossRef" href="#bib0920"><span class="elsevierStyleSup">37</span></a> Tsay et al.<a class="elsevierStyleCrossRef" href="#bib1095"><span class="elsevierStyleSup">72</span></a> discovered that, compared to controls, patients with lung carcinoma had higher levels of the oral bacterial population, mainly Streptococci and Veillonella. Tsay el al. found that PI3K and ERK (MAP kinase pathway) activation have been linked to the higher incidence of oral taxa. In this <span class="elsevierStyleItalic">in vitro</span> investigation, airway epithelial cells exposed to bacteria (<span class="elsevierStyleItalic">Veillonella</span>, <span class="elsevierStyleItalic">Prevotella</span>, and <span class="elsevierStyleItalic">Streptococci</span>) exhibited an upregulation of certain signaling pathways, such as ERK and PI3K pathways. Scientists attempted to link these signaling pathways to lung neoplasm as upregulation of these pathways by commensal microbiota dysbiosis promotes cancer development and progression.<a class="elsevierStyleCrossRef" href="#bib1100"><span class="elsevierStyleSup">73</span></a> The presence of <span class="elsevierStyleItalic">Staphylococcus</span> in the microbiota is rare compared to Streptococcus, which is previously linked with lung cancer.<a class="elsevierStyleCrossRef" href="#bib1105"><span class="elsevierStyleSup">74</span></a> This finding suggests that the former plays a harmful role and the latter a protective role in the growth of lung cancer. Another study, however, showed that while streptococcus may contribute to cancer prevention, Staphylococcus may cause DNA damage.<a class="elsevierStyleCrossRef" href="#bib1110"><span class="elsevierStyleSup">75</span></a> Through specific microbial components like toxins, dysregulation of lung microbial populations probably fosters alterations to carcinogenic pathways.<a class="elsevierStyleCrossRef" href="#bib1115"><span class="elsevierStyleSup">76</span></a> For instance, Apopa and colleagues<a class="elsevierStyleCrossRef" href="#bib1120"><span class="elsevierStyleSup">77</span></a> found a significant amount of cyanobacteria in non-small cell lung cancer (NSCLC) samples and linked the cyanobacteria's toxin to inflammation-associated lung cancer growth. On the other hand, Yaghoobi and colleagues<a class="elsevierStyleCrossRef" href="#bib1125"><span class="elsevierStyleSup">78</span></a> showed that some gram-negative bacteria's cytolethal distending toxin (CDT) have anticancer effects on A549 cell lines.</p><p id="par0080" class="elsevierStylePara elsevierViewall">Incorporating a deeper mechanistic perspective into the review of probiotics’ potential in lung cancer management can significantly enhance its scientific rigor and utility for future research. To achieve this, the manuscripts should prioritize studies that offer comprehensive molecular insights. Key among these are investigations employing molecular biology techniques such as gene expression analysis and proteomics, which can elucidate the interactions between probiotics and lung cancer cells or the tumor microenvironment. An emphasis on signaling pathways is crucial, given that probiotics often exert their effects through pathways like NF-kB, PI3K/Akt, and MAPK, known for their roles in inflammation, cell proliferation, apoptosis, and immune responses.<a class="elsevierStyleCrossRef" href="#bib1130"><span class="elsevierStyleSup">79</span></a> Additionally, the impact of microbial metabolites, such as short-chain fatty acids, on cellular processes offers a layer of mechanistic detail, highlighting how these substances modulate immune responses and exhibit anti-tumorigenic properties.<a class="elsevierStyleCrossRef" href="#bib1135"><span class="elsevierStyleSup">80</span></a> The role of the immune system in mediating the anti-cancer effects of probiotics is another vital area of focus. Detailing the modulation of cytokine balance, activation of dendritic cells, natural killer cells, and T cells, and the potential induction of cancer cell apoptosis can provide a comprehensive overview of immune-mediated mechanisms.<a class="elsevierStyleCrossRefs" href="#bib1140"><span class="elsevierStyleSup">81–83</span></a></p><p id="par0085" class="elsevierStylePara elsevierViewall">Probiotics have shown diverse impacts on the host and its immune system. Several bacterial strains have the ability to influence the environment within the gut, the protective barrier of the intestines, and they may control the immune system of the intestinal lining. Probiotics may influence several cells that play a crucial role in both the innate and acquired immune responses, such as dendritic cells (DCs), monocytes, Natural Killer (NK) cells, macrophages, lymphocytes, and epithelial cells. Specifically, they may stimulate the pattern recognition receptors (PRRs) found on both immune cells (such as M cells in Peyer's patches) and non-immune cells (such as intestinal epithelial cells). TLRs, among PRRs, have been extensively researched due to their ability to initiate signaling cascades that result in cell proliferation and the release of cytokines, thereby regulating the immune system. Research has shown that the immune system's response to probiotic bacteria may be attributed to the production of anti-inflammatory cytokines in the gastrointestinal tract. Particular strains of probiotics have the ability to stimulate dendritic cells (DCs), which then carry the antigens to nearby lymph nodes, resulting in the production of IL-10 and IL-12. In this context, Dendritic Cells (DCs) stimulate the development of unspecialized T and B cells into their specific subgroups, using a range of cytokines. Specifically, immature Th cells have the ability to develop into Treg, Th1, and Th2 immune cells. B cells may also transform into plasma cells, which are important in humoral responses, or regulatory B (Breg) cells, that contribute to the production of tumor growth factor (TGF)-β or IL-10. In addition, dendritic cells (DCs) may induce the activation of natural killer (NK) cells by producing cytokines including IL-12 and IL-15. Various Lactic Acid Bacteria (LAB) and other probiotic microbes may stimulate the production of IFN-γ by NK cells <span class="elsevierStyleItalic">via</span> the involvement of DCs.<a class="elsevierStyleCrossRef" href="#bib1155"><span class="elsevierStyleSup">84</span></a></p><p id="par0090" class="elsevierStylePara elsevierViewall">Based on the contribution of probiotics to intestinal health, it is currently believed that the core benefit of probiotics is to maintain healthy intestinal flora and support a healthy immune system through nonspecific and specific physiological effects (<a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a>).<a class="elsevierStyleCrossRef" href="#bib1160"><span class="elsevierStyleSup">85</span></a></p><elsevierMultimedia ident="fig0015"></elsevierMultimedia></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Prebiotics, probiotics, and antibiotics that target bacteria</span><p id="par0095" class="elsevierStylePara elsevierViewall">Probiotics, prebiotics, and synbiotics are examples of mature microbiome-targeting products that have just hit the commercial market and have demonstrated general safety in various clinical settings. The general effects include improved gastrointestinal steadiness, immunomodulation and obesity, and diet management by regulating microbial metabolism of dietary fibers by producing SCFAs, taking part in the digestive processes, and neutralizing inflammatory and carcinogenic agents, according to growing clinical evidence.<a class="elsevierStyleCrossRef" href="#bib1165"><span class="elsevierStyleSup">86</span></a> On the other hand, pharmaceutical and biotechnological sectors are looking for microbial therapeutic techniques to develop and market chemotherapeutic and targeted cancer medicines. A clinical experiment revealed a therapeutic advantage of giving neomycin concurrently with irinotecan to minimize the adverse effects of chemotherapy.<a class="elsevierStyleCrossRef" href="#bib1170"><span class="elsevierStyleSup">87</span></a> Chemotherapy-related side effects may be lessened by medications that target microbiomes. In different preclinical studies, small molecule inhibitors of bacterial glucuronidase were introduced to animals and were protected against diarrhea caused by anticancer drugs. However, the optimal ways to analyze the host microbiome are not well understood given the current state of research and information regarding the beneficial microbiota and molecular pathways.<a class="elsevierStyleCrossRef" href="#bib1175"><span class="elsevierStyleSup">88</span></a> It is yet unclear if the microbial changes may result in unanticipated localized homeostatic abnormalities, inflammatory reactions, or even precancerous lesions. The function of existing probiotic strains can be enhanced by applying bioengineering techniques which involve the artifices of a gene of a probiotic strain for promoting the clemency to the technological stress, including but not specified to high temperature, oxygen, acidification, production process, and/or survival of the probiotic in the GIT, to offer significant function to the host.<a class="elsevierStyleCrossRef" href="#bib1180"><span class="elsevierStyleSup">89</span></a> This advanced approach can be utilized to develop newer probiotic strains isolated from the pathogens. It permits for the development of proteins which were previously not present within the microorganism. Virulence factors of the pathogens can be reproduced and expressed into the probiotic strain and posterior administration of the attendant recombinant probiotic strain will inhibit the development of infection with no clinical expression of the signs. However, bio-engineered probiotics are able to transport therapeutics or vaccines, pathogens or toxins, promotes the immune response and imitate cell surface receptors.<a class="elsevierStyleCrossRef" href="#bib1185"><span class="elsevierStyleSup">90</span></a> Bioengineered probiotics are currently being researched as to target transportation of definite genes identified toward a specific foodborne pathogen. The major limitations of bioengineered probiotics are they are categorized as genetically modified organisms (GMO).<a class="elsevierStyleCrossRef" href="#bib1190"><span class="elsevierStyleSup">91</span></a></p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Probiotics in the management of lung cancer</span><p id="par0100" class="elsevierStylePara elsevierViewall">Distinct differences in the gut microbiota between lung cancer patients and healthy individuals have been documented, suggesting potential implications for prognosis and therapeutic strategies. By modifying the development of regulatory T cells, the gut microbiota may have a major impact on immunotherapy and may affect immunomodulation pathways.<a class="elsevierStyleCrossRef" href="#bib1195"><span class="elsevierStyleSup">92</span></a> The same researchers discovered that using <span class="elsevierStyleItalic">Akkermansia muciniphila</span> supplements boosts immune therapy responsiveness, while aberrant gut microbiota composition is linked to treatment resistance.<a class="elsevierStyleCrossRef" href="#bib1200"><span class="elsevierStyleSup">93</span></a> Immunotherapy, especially checkpoint inhibitors, has been widely applied in patients with lung cancer.<a class="elsevierStyleCrossRef" href="#bib1205"><span class="elsevierStyleSup">94</span></a> However, a subset of patients experiences dramatic response to these agents. The predictive factors of response to checkpoint inhibitors are the subject of debate.<a class="elsevierStyleCrossRef" href="#bib1210"><span class="elsevierStyleSup">95</span></a> Patients with lung cancer who react to immunotherapy have dramatically different gut flora from those who do not. Furthermore, it was demonstrated that in lung cancer patients, the predominance of the <span class="elsevierStyleItalic">A. muciniphila</span> species was positively associated with a considerably high response to anti-PD-1 therapy.<a class="elsevierStyleCrossRefs" href="#bib1195"><span class="elsevierStyleSup">92,93</span></a> It was further observed that a particular group of gut microbiota, namely <span class="elsevierStyleItalic">Firmicutes</span>, <span class="elsevierStyleItalic">Proteobacteria</span>, <span class="elsevierStyleItalic">Actinobacteria</span>, and <span class="elsevierStyleItalic">Bacteroidetes</span>, had boosted the response to anti-PD-1 immunotherapy.<a class="elsevierStyleCrossRef" href="#bib1215"><span class="elsevierStyleSup">96</span></a> This effect might be due to the stimulatory effects of probiotics on the mitochondria of immune cells,<a class="elsevierStyleCrossRef" href="#bib1220"><span class="elsevierStyleSup">97</span></a> which improves the immune cells’ activation following immunotherapy.<a class="elsevierStyleCrossRef" href="#bib1225"><span class="elsevierStyleSup">98</span></a> Moreover, patients with NSCLCs who responded to nivolumab had a gut microbiota with a more varied makeup than those who did not. Additionally, it was discovered that patients with high microbiome diversity had longer progression-free survival time than patients with low microbiome diversity. A medical examination report of systemic immune disease assessed by flow cytometry showed that patients had a high concentration of CD4<span class="elsevierStyleSup">+</span> and CD8<span class="elsevierStyleSup">+</span> Tcells due to higher gut microbiome diversity, especially memory and natural killer (NK) cells in response to anti-PD-1.<a class="elsevierStyleCrossRef" href="#bib1230"><span class="elsevierStyleSup">99</span></a> A retrospective study on 118 patients with advanced NSCLC receiving immunotherapy followed by supplement therapy with <span class="elsevierStyleItalic">Clostridium butyricum</span> (before and after immunotherapy) demonstrated a significantly longer progression-free survival and overall survival rate.<a class="elsevierStyleCrossRef" href="#bib1235"><span class="elsevierStyleSup">100</span></a> Along with the known improvement in response to immunotherapy, these gut microbiotas can affect the lung cancer cells’ response to cytotoxic chemotherapies. In a lung cancer mouse model, for instance, oral administration of <span class="elsevierStyleItalic">Lactobacillus acidophilus</span> along with the anti-cancer drug cisplatin enhanced the anti-cancer efficacy of cisplatin by reducing the tumor size and increasing the survival rate. These findings suggest that the anti-neoplastic characteristics, such as pro-apoptotic and anti-growth activity of cisplatin, are promisingly moderated by introducing probiotics.<a class="elsevierStyleCrossRef" href="#bib1240"><span class="elsevierStyleSup">101</span></a> Additionally, patients with advanced-stage lung cancer receiving <span class="elsevierStyleItalic">E. hirae</span> and <span class="elsevierStyleItalic">Barnesiella intestinihominis</span> together with chemotherapy and immunotherapy experienced prolonged progression-free survival.<a class="elsevierStyleCrossRef" href="#bib1245"><span class="elsevierStyleSup">102</span></a> As a result, the improved immunomodulatory impact can be credited with enhanced survival of these individuals. However, further research is required to determine the involvement of the gut microbiota in the onset and lung cancer progression, as well as to study and assess the possible roles of the microbiome in the successful regulation of anticancer therapy.</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Probiotic therapy and next-generation probiotics</span><p id="par0105" class="elsevierStylePara elsevierViewall">Probiotics, defined as specific bacterial strains that enhance human health without inducing antibiotic resistance in other microbiota members, have garnered attention for their therapeutic potential. Some of the bacteria in probiotics may travel to the colon to experience the specific gut ecology, metabolisms, and physiology. Probiotics may not always require settling in the targeted organs (gut and lungs).<a class="elsevierStyleCrossRef" href="#bib1250"><span class="elsevierStyleSup">103</span></a> Probiotics, by definition must be safe for use in animals, tolerant to bile acids and acidity, and should be capable of adhering to and colonizing in the intestine. The information that is now available suggests that probiotic bacteria can have an impact on a range of immunological parameters, including humoral, cellular, and nonspecific immunity, as well as the immune system as a whole. New evidence suggests that probiotics affect nonspecific host defences and enhance NK cell function in aged individuals. In older mice receiving probiotic supplements, the age-associated decline in cytokine generation was shown to be reversed. Probiotics have resulted in enhanced immunomodulatory function by following several mechanisms such as influence of neutrophils and secretory IgA, induced development of mucus, activated macrophage by <span class="elsevierStyleItalic">Lactobacilli</span> signaling, inhibition of pro-inflammatory cytokine release, and by enhancing the peripheral immunoglobulin levels. Probiotics can also alter the cytokine secretion and phenotype of the DC surface. The management of toxicity, side effects, and inflammation brought on by chemotherapy in cancer patients appears to require other microorganisms. The administration of gemcitabine along with probiotics containing specific microbiota such as <span class="elsevierStyleItalic">Lactobacilli</span> and <span class="elsevierStyleItalic">Bifidobacteri</span>, has demonstrated noteworthy efficacy in the reduction of hematological toxic impact, influencing RBCs, platelet count, as well as improved aspartate aminotransferase (AST) level, gamma-glutamyl transferase (GGT), creatinine, and urea levels in mice as compared to mice receiving chemotherapy alone.<a class="elsevierStyleCrossRef" href="#bib1255"><span class="elsevierStyleSup">104</span></a> The vast majority of regularly prescribed traditional probiotics, such as Saccharomyces species, Enterococcus, Streptococcus <span class="elsevierStyleItalic">Bifidobacterium</span>, <span class="elsevierStyleItalic">Lactobacillus</span>, and numerous others, were selected by chance or as a result of a personal experience of an individual. Traditional probiotic administration, on the other hand, does not specifically target any disorders. Many prospective NGPs are now being developed vigorously thanks to investigations employing the most recent generation of sequencing and bioinformatics tools. A class of organisms created specifically for medicinal purposes and as novel preventive interventions is included in emerging NGPs.</p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Probiotics in the management of lung cancer</span><p id="par0110" class="elsevierStylePara elsevierViewall">It is required to comprehend how the lung microbiota is associated with the wellness and disease of the lungs, including lung metastasis. Therefore, to accomplish the right diagnosis and treatment of lung carcinogenesis, discovering new therapeutic target(s) for the lungs’ microbial environment is essential.<a class="elsevierStyleCrossRef" href="#bib1260"><span class="elsevierStyleSup">105</span></a> Identifying whether the microbe has a direct role in disease pathogenesis or whether the healthy microbial population of the person declines after the onset of the disease is crucial. Though there is still a paucity of evidence supporting the prevention of lung cancer with probiotics, certain research has found promising results. According to a study, a healthy intestinal microbiota may act as a preventative measure in the treatment of cancer.<a class="elsevierStyleCrossRef" href="#bib1265"><span class="elsevierStyleSup">106</span></a> It has been suggested in a newly reviewed body of literature that metagenomics, meta-transcriptomics, and culturomics platforms are making it possible to compare the cancer patients’ and healthy subjects’ microbiomes. Together, the data may indicate which bacterial genera or species would be helpful to patients.<a class="elsevierStyleCrossRef" href="#bib1270"><span class="elsevierStyleSup">107</span></a> Therefore, using microorganisms or their by-products to treat cancer may also be able to treat tumors. It was found that the development of cancer-initiating toxins and metabolites by bacteria may also have a crucial role on cancer progression. In order to directly target the malignant cells in future treatments, it will be necessary to combine the use of immunotherapeutics and more traditional methods with the use of microbiomes and their products.</p><p id="par0115" class="elsevierStylePara elsevierViewall">Radiotherapy and chemotherapy are the mainstay of cancer treatments.<a class="elsevierStyleCrossRefs" href="#bib1275"><span class="elsevierStyleSup">108,109</span></a> The application of chemotherapy and radiotherapy is limited by their severe adverse effects.<a class="elsevierStyleCrossRef" href="#bib1285"><span class="elsevierStyleSup">110</span></a> Recently, it has been demonstrated that probiotics can be applied in reducing the adverse effects of radiotherapy and chemotherapy.<a class="elsevierStyleCrossRef" href="#bib1290"><span class="elsevierStyleSup">111</span></a><a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a> summarizes the studies examining the use of probiotics in the treatment of people with the progression of lung carcinoma, animals bearing lung cancer, and a few <span class="elsevierStyleItalic">in vitro</span> research studies employing lung and other cancerous cell lines. These studies documented how probiotics affect lung metastasis, checkpoint inhibitors, homeostasis, and the increased effectiveness of anti-tumor drugs. Lung cancer treatment with recombinant probiotic bacteria, particularly Bifidobacterium infantis, have also been discussed.<a class="elsevierStyleCrossRefs" href="#bib0760"><span class="elsevierStyleSup">5,101,102,104,106,112–119</span></a></p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0120" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a> summarizes the potential therapeutic impact of diverse probiotic strains on the prevention of various cancer types. Concurrently, the table discusses the plausible anticancer effects associated with these probiotics, providing a comprehensive overview of their preventive capabilities.<a class="elsevierStyleCrossRefs" href="#bib1235"><span class="elsevierStyleSup">100,120–132</span></a></p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Potential role of probiotics in supportive care or symptom management</span><p id="par0125" class="elsevierStylePara elsevierViewall">The potential role of probiotics in supportive care or symptom management for lung cancer patients has gained increasing attention in recent years. Probiotics, defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host, have been explored for their ability to alleviate treatment-related side effects and improve the overall quality of life in cancer patients, including those undergoing treatment for lung cancer.</p><p id="par0130" class="elsevierStylePara elsevierViewall">Research indicates that probiotics may play a significant role in managing gastrointestinal side effects commonly associated with cancer treatments such as chemotherapy and radiation therapy. These side effects often include diarrhea, constipation, and mucositis, which can severely impact patients’ quality of life. Probiotics are thought to restore the gut microbiota balance disrupted by cancer treatments, thereby reducing the incidence and severity of these gastrointestinal symptoms. For example, a study found that probiotic supplementation reduced the severity and duration of radiation-induced diarrhea in patients with abdominal and pelvic cancers, including a subset of lung cancer patients undergoing combined chemoradiation therapy.<a class="elsevierStyleCrossRef" href="#bib1355"><span class="elsevierStyleSup">124</span></a> Similarly, another clinical trial demonstrated that probiotics could effectively prevent chemotherapy-induced diarrhea in cancer patients, suggesting their potential role in supportive care across various cancer types, including lung cancer.<a class="elsevierStyleCrossRef" href="#bib1400"><span class="elsevierStyleSup">133</span></a></p><p id="par0135" class="elsevierStylePara elsevierViewall">Beyond gastrointestinal symptoms, probiotics have been investigated for their potential to enhance overall immune function, which could be compromised in lung cancer patients undergoing treatment. A robust immune system is crucial for managing infections and maintaining general health, which, in turn, can improve patients’ quality of life. Research has shown that probiotic intake can increase the activity of natural killer cells and other aspects of the immune response in elderly patients, which could be beneficial for lung cancer patients experiencing immunosuppression due to their treatment or the cancer itself.<a class="elsevierStyleCrossRef" href="#bib1405"><span class="elsevierStyleSup">134</span></a></p><p id="par0140" class="elsevierStylePara elsevierViewall">Furthermore, there's a growing interest in the psychological benefits of probiotics, given the gut–brain axis's role in regulating mood and cognitive functions. Given that lung cancer patients often experience high levels of stress, anxiety, and depression, probiotics could offer a supportive care avenue to improve mental health and quality of life. A recent review had highlighted the potential of probiotics in reducing symptoms of depression and anxiety, which could be particularly relevant for patients coping with the psychological burden of cancer.<a class="elsevierStyleCrossRef" href="#bib1410"><span class="elsevierStyleSup">135</span></a> Overall, the exploration of probiotics as a supportive care option in lung cancer treatment is promising. Their potential to mitigate treatment-related side effects, enhance immune function, and possibly improve psychological well-being could significantly contribute to the holistic management of lung cancer patients, improving their quality of life during and after treatment. However, more targeted clinical trials and research are needed to fully understand the scope and mechanisms of probiotics in this context and to develop specific, evidence-based recommendations for their use in lung cancer patients.</p></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Practical considerations for incorporating probiotics in lung cancer treatment protocols</span><p id="par0145" class="elsevierStylePara elsevierViewall">Integrating probiotics into lung cancer treatment protocols presents a promising research direction with the potential for tangible clinical benefits, yet necessitating careful consideration of several practical aspects to ensure both feasibility and safety. The selection of specific probiotic strains is paramount, as their effects can vary significantly. Strains such as <span class="elsevierStyleItalic">Lactobacillus rhamnosus</span> GG and <span class="elsevierStyleItalic">Bifidobacterium longum</span> are notable for their demonstrated benefits in lung health and cancer mitigation through preclinical studies, emphasizing the importance of strain specificity.<a class="elsevierStyleCrossRefs" href="#bib1415"><span class="elsevierStyleSup">136,137</span></a> Additionally, the quality and viability of these strains are critical for their effectiveness, necessitating recommendations for products adhering to rigorous manufacturing standards to ensure the presence of live, active cultures.<a class="elsevierStyleCrossRef" href="#bib1425"><span class="elsevierStyleSup">138</span></a> However, the optimal dosing and timing for administering probiotics within lung cancer therapy remain undefined, with ongoing research aiming to establish these parameters to enhance the therapeutic benefits while minimizing potential interactions with conventional treatments.<a class="elsevierStyleCrossRef" href="#bib1430"><span class="elsevierStyleSup">139</span></a> The potential challenges in incorporating probiotics into cancer care include interactions with existing cancer therapies, such as chemotherapy and immunotherapy, which require a deep understanding to prevent adverse effects and safeguard patient safety.<a class="elsevierStyleCrossRef" href="#bib1335"><span class="elsevierStyleSup">120</span></a> Furthermore, the immunomodulatory properties of probiotics call for caution in patients with compromised immune systems, due to risks like bacteraemia or fungemia.<a class="elsevierStyleCrossRef" href="#bib1435"><span class="elsevierStyleSup">140</span></a> Another significant hurdle is the variability in probiotic formulations and the regulatory landscape across different jurisdictions, underscoring the need for standardized formulations and guidelines to facilitate clinical application.<a class="elsevierStyleCrossRef" href="#bib1440"><span class="elsevierStyleSup">141</span></a> Conclusively, while the use of probiotics in lung cancer treatment schemes opens new avenues for improving patient outcomes by exploiting the gut–lung axis, the realization of their full potential hinges on the outcomes of rigorous clinical trials aimed at determining their efficacy, safety, and optimal use in this particular cohort. The successful integration of probiotics into clinical practice will likely depend on a collaborative effort among researchers, healthcare practitioners, and regulatory authorities to overcome the intricate challenges associated with their implementation in cancer care.</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Key knowledge gaps and future research directions</span><p id="par0150" class="elsevierStylePara elsevierViewall">Addressing the role of probiotics in lung cancer management, especially in terms of supportive care and symptom alleviation, necessitates a critical understanding of the limitations inherent in the current body of research, alongside a keen identification of existing knowledge gaps. These gaps not only underscore our present understanding but also chart a course for imminent research endeavors. By delineating these areas explicitly, we will be positioned to articulate specific research questions and hypotheses that could catalyze future investigative efforts, thereby enhancing our grasp and utilization of probiotics in the context of lung cancer treatment.</p><p id="par0155" class="elsevierStylePara elsevierViewall">Among the pivotal areas awaiting exploration is the identification of optimal probiotic strains and combinations that are particularly efficacious for lung cancer patients. Despite various strains being acknowledged for their health-promoting attributes, discerning those that specifically ameliorate treatment-related side effects and bolster patient quality of life are imperative. Comparative analyses across different strains could shed light on benefits uniquely pertinent to lung cancer patient care.<a class="elsevierStyleCrossRef" href="#bib1445"><span class="elsevierStyleSup">142</span></a> Furthermore, the establishment of effective dosing regimens and appropriate timing for probiotic administration within lung cancer therapeutic protocols remains elusive. There's a compelling need for dosing studies to devise evidence-backed guidelines that amplify probiotics’ therapeutic impacts, with investigations into the timing of administration potentially optimizing efficacy and mitigating adverse reactions.<a class="elsevierStyleCrossRef" href="#bib1450"><span class="elsevierStyleSup">143</span></a></p><p id="par0160" class="elsevierStylePara elsevierViewall">The interplay between probiotics and conventional lung cancer therapies, such as chemotherapy and radiation, presents a fertile ground for research into possible synergistic effects that might amplify treatment outcomes or diminish negative side effects. The dynamics between probiotics and emerging therapies, including immunotherapy, also warrant thorough exploration.<a class="elsevierStyleCrossRef" href="#bib1455"><span class="elsevierStyleSup">144</span></a> Additionally, while the advantageous effects of probiotics are increasingly acknowledged, the mechanisms underpinning these benefits, especially within the cancer treatment milieu, demand deeper investigation. Studies at the molecular and cellular levels could illuminate the interactions between probiotics, the host immune system, the microbiota, and cancer cells, providing valuable mechanistic insights.<a class="elsevierStyleCrossRef" href="#bib1460"><span class="elsevierStyleSup">145</span></a></p><p id="par0165" class="elsevierStylePara elsevierViewall">The call for more rigorous clinical trials is unmistakable, with an emphasis on not just evaluating the safety and efficacy of probiotics for lung cancer patients but also on patient-centered outcomes such as quality of life and treatment satisfaction. These investigations should account for patient diversity and the influence of variables like age, sex, cancer stage, and treatment modality on the effectiveness of probiotics.<a class="elsevierStyleCrossRef" href="#bib1465"><span class="elsevierStyleSup">146</span></a> Lastly, the long-term implications of probiotic use on lung cancer survivorship, including its potential in bolstering immune health, preventing recurrence, and enhancing overall well-being, represent a significant domain for future research.<a class="elsevierStyleCrossRef" href="#bib1470"><span class="elsevierStyleSup">147</span></a> This comprehensive approach to investigating probiotics in lung cancer management underscores a multidimensional endeavor that could significantly advance our understanding and application in this field.</p></span></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Conclusions</span><p id="par0170" class="elsevierStylePara elsevierViewall">Employing biotherapeutics for the treatment of respiratory diseases, including lung cancer, constitutes a forward-thinking approach. These microorganisms primarily alter the gut microbiota through immunomodulation. As we learn more about the relationship between micro-organisms in various organ systems and the immune system, it will be easier to design probiotic-based therapies. Even though clinical trials have produced intriguing and good results, more research is needed to identify optimal strains, precisely describe reaction apparatuses, and assess the effects of probiotics to fully realize the benefits. Specific forms and stages of lung cancer call for extensive human clinical trials. In our opinion, various probiotic bacterial strains, in combination with additional immunotherapeutic medications or different forms of therapy, may be accepted as further therapy for the prevention or management of lung cancer.</p></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Authors’ contributions</span><p id="par0175" class="elsevierStylePara elsevierViewall">Blinded for review.</p></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Institutional review board statement</span><p id="par0180" class="elsevierStylePara elsevierViewall">N.A.</p></span><span id="sec0090" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Informed consent statement</span><p id="par0185" class="elsevierStylePara elsevierViewall">N.A.</p></span><span id="sec0095" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Data availability statement</span><p id="par0190" class="elsevierStylePara elsevierViewall">N.A.</p></span><span id="sec0100" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Funding</span><p id="par0195" class="elsevierStylePara elsevierViewall">N.A.</p></span><span id="sec0105" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Conflicts of interest</span><p id="par0200" class="elsevierStylePara elsevierViewall">The authors declare that they have no competing interests.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:13 [ 0 => array:3 [ "identificador" => "xres2290665" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1903020" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 3 => array:3 [ "identificador" => "sec0010" "titulo" => "Methods" "secciones" => array:12 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Gut–lung axis" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Lung microbiomes and host immunity" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Lung microbiome and host metabolism" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "Microbiota and lung cancer" ] 4 => array:2 [ "identificador" => "sec0035" "titulo" => "The role of microbiota in specific lung cancers" ] 5 => array:2 [ "identificador" => "sec0040" "titulo" => "Prebiotics, probiotics, and antibiotics that target bacteria" ] 6 => array:2 [ "identificador" => "sec0045" "titulo" => "Probiotics in the management of lung cancer" ] 7 => array:2 [ "identificador" => "sec0050" "titulo" => "Probiotic therapy and next-generation probiotics" ] 8 => array:2 [ "identificador" => "sec0055" "titulo" => "Probiotics in the management of lung cancer" ] 9 => array:2 [ "identificador" => "sec0060" "titulo" => "Potential role of probiotics in supportive care or symptom management" ] 10 => array:2 [ "identificador" => "sec0065" "titulo" => "Practical considerations for incorporating probiotics in lung cancer treatment protocols" ] 11 => array:2 [ "identificador" => "sec0070" "titulo" => "Key knowledge gaps and future research directions" ] ] ] 4 => array:2 [ "identificador" => "sec0075" "titulo" => "Conclusions" ] 5 => array:2 [ "identificador" => "sec0080" "titulo" => "Authors’ contributions" ] 6 => array:2 [ "identificador" => "sec0085" "titulo" => "Institutional review board statement" ] 7 => array:2 [ "identificador" => "sec0090" "titulo" => "Informed consent statement" ] 8 => array:2 [ "identificador" => "sec0095" "titulo" => "Data availability statement" ] 9 => array:2 [ "identificador" => "sec0100" "titulo" => "Funding" ] 10 => array:2 [ "identificador" => "sec0105" "titulo" => "Conflicts of interest" ] 11 => array:2 [ "identificador" => "xack786125" "titulo" => "Acknowledgments" ] 12 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2024-02-20" "fechaAceptado" => "2024-04-10" "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1903020" "palabras" => array:4 [ 0 => "Probiotics" 1 => "Lung cancer" 2 => "Gut–lung axis" 3 => "Immune system" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Lung cancer remains the leading cause of cancer-related deaths worldwide. According to the American Cancer Society (ACS), it ranks as the second most prevalent type of cancer globally. Recent findings have highlighted bidirectional gut–lung interactions, known as the gut–lung axis, in the pathophysiology of lung cancer. Probiotics are live microorganisms that boost host immunity when consumed adequately. The immunoregulatory mechanisms of probiotics are thought to operate through the generation of various metabolites that impact both the gut and distant organs (<span class="elsevierStyleItalic">e.g.</span>, the lungs) through blood. Several randomized controlled trials have highlighted the pivotal role of probiotics in gut health especially for the prevention and treatment of malignancies, with a specific emphasis on lung cancer. Current research indicates that probiotic supplementation positively affects patients, leading to a suppression in cancer symptoms and a shortened disease course. While clinical trials validate the therapeutic benefits of probiotics, their precise mechanism of action remains unclear. This narrative review aims to provide a comprehensive overview of the present landscape of probiotics in the management of lung cancer.</p></span>" ] ] "multimedia" => array:5 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2146 "Ancho" => 2333 "Tamanyo" => 512756 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">The function of the microbiome in lung cancer. Schematic illustration of lung microbiota to maintain homeostasis and cancer development. In the biology of lung cancer, the microbiota plays a number of functions and employs a range of techniques. The protagonists of the tumor microenvironment are bacteria found in the lungs and upper respiratory system, as well as those with intra-tumor and intracellular locations. The gut microbiota is crucial in influencing how the immune system reacts and how inflamed the body is. This is in addition to the bacteria involved in bloodstream translocation events. It's also possible that certain bacterial toxins with the potential to activate oncogenic pathways might alter lung function. Additionally, cigarette smoke and pollution are the two main causes of the dysbiotic changes in the lungs. Finally, the microbiome may affect metastatic pathways by increasing the production of vascular endothelial growth factors and promoting inflammation.</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 2418 "Ancho" => 2500 "Tamanyo" => 629374 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">The interactions between lung cancer tumor microenvironment and lung microbiota.</p>" ] ] 2 => array:7 [ "identificador" => "fig0015" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 1977 "Ancho" => 3583 "Tamanyo" => 550594 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">The effects of probiotics on the host (SCFAs, short-chain fatty acids; sIgA, soluble IgA; GPR, G protein coupled free fatty acid receptor; DC cell, dendritic cell; Treg cell, regulatory T cell; Th17, T helper cell 17; ILC3, Type 3 innate lymphocyte; NK cell, Natural killer cell; LPS, lipopolysaccharide; TLR4, Toll-like receptor 4; NF-κβ, nuclear factor-κB).<a class="elsevierStyleCrossRef" href="#bib1160"><span class="elsevierStyleSup">85</span></a></p>" ] ] 3 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Cells/disease \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Study type \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Probiotic strain/animal model \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Findings \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Ref. \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Lewis lung carcinoma (LLC) (3 lines) and hepatoma (10lines) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">In vivo</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Lactobacillus casei</span> in mice and guinea pig animal models \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Increased longevity and prevention of pulmonary metastases. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib1255"><span class="elsevierStyleSup">104</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Solid tumor (sarcoma 37) and metastatic 3LL \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">In vivo</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Saccharomyces cerevisiae</span> 14K and <span class="elsevierStyleItalic">Enterococcus faecium</span> K-50 (C57B16 mice and Balb/c) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Prebiotic significantly decreased metastases compared to animals that just received the vaccination. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib1295"><span class="elsevierStyleSup">112</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Lung cancer \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">In vivo</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Gene (sFlt-1 gene) transfer system through <span class="elsevierStyleItalic">Bifidobacterium infantis</span>. A recombinant technology in mice \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">LLC C57BL/6 mice with reduced tumor development and longer survival times. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib1300"><span class="elsevierStyleSup">113</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Lung cancer \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">In vivo</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Bacterium (<span class="elsevierStyleItalic">Bifidobacterium infantis</span>) mediated receptor (sKDR) insert in mice. sKDR is a soluble kinase insert domain receptor \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">By boosting the tumor's rate of necrosis and extending the mice's survival, the tumor grows less quickly (LLC C57BL/6 mice). \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib1265"><span class="elsevierStyleSup">106</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Lung metastasis of melanoma \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">In vivo</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Commensal microbiota (C57BL/6 mice) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Following antibiotic therapy, changes in the microbiota led to the activation of NK cells. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib1305"><span class="elsevierStyleSup">114</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Lung cancer \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">In vivo</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Lactobacillus acidophilus</span> (C57BL/6J mice) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cisplatin's anti-tumor effects were enhanced when combined with <span class="elsevierStyleItalic">L. acidophilus</span> and diminished when combined with ABX. Probiotics and cisplatin given together boosted survival rates. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib1240"><span class="elsevierStyleSup">101</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Breast and lungs cancer \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">In vitro</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Lactococcus lactis</span> NK34 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">>77% of cytotoxic activity. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib0760"><span class="elsevierStyleSup">5</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Lung, breast, and cervical cancer \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">In vitro</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Lactococcus lactis</span> KC24 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Strong cytotoxic action, excluding cells that are cervical cancer-related. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib1310"><span class="elsevierStyleSup">115</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Melanoma \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">In vivo</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Bifidobacterium breve</span>, <span class="elsevierStyleItalic">B. cocktail</span>, <span class="elsevierStyleItalic">B. lomgum</span>, <span class="elsevierStyleItalic">B. bifidum</span>, and <span class="elsevierStyleItalic">B. lactis</span> in C57BL/6 mice \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">The similar level of tumor control as PD-L1-specific antibody therapy (checkpoint blockade). \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib1315"><span class="elsevierStyleSup">116</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Metastatic melanoma or non–small cell lung carcinoma (NSCLC) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">In vivo</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Germ free mice and <span class="elsevierStyleItalic">Bacteroides fragilis</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Immunostimulatory effects of CTLA-4 blockade. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib1320"><span class="elsevierStyleSup">117</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Breast cancer and lung metastasis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">In vivo</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Lactobacillus. casei</span> and CRL 431 BALB/c mice \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Reduced tumor vascularity, extravasation of tumor cells, and lung metastasis; decreased tumor growth. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib1325"><span class="elsevierStyleSup">118</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Breast cancer and lung metastasis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">In vivo</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Kefir used as a probiotic with fermented milk/BALB/c mice \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Significantly less metastases to the lung and bone marrow and an increase in helper and cytotoxic T cells. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib1330"><span class="elsevierStyleSup">119</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Advanced lung and ovarian cancer patients \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">In vivo</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Barnesiella intestinihominis</span> and <span class="elsevierStyleItalic">Enterococcus hirae</span>/C57BL/6J mice \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Enhanced antitumor properties of cyclophosphamide. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib1245"><span class="elsevierStyleSup">102</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab3710929.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Impact of probiotics, applied models (<span class="elsevierStyleItalic">in vitro</span> and <span class="elsevierStyleItalic">in vivo</span>), and major findings in the treatment of lungs tumor and metastasis.</p>" ] ] 4 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">No \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Anticancer drugs \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Cancer type \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Antibiotic mechanism \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Ref. \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Bifidobacterium lactis Bb12, Lactobacillus rhamnosus GG, Lactobacillus rhamnosus 573</span><span class="elsevierStyleItalic">Bifidobacterium longum, Lactobacillus acidophilus, Enterococcus faecalis</span><span class="elsevierStyleItalic">Lactobacillus acidophilus LA-11</span>, <span class="elsevierStyleItalic">Lactobacillus acidophilus</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Colorectal cancer \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">↓ Chronic inflammation associated with cancer↓ WT1-expressing tumor growth↓ Azoreductase, nitroreductase and glucuronidase activity \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRefs" href="#bib1335"><span class="elsevierStyleSup">120,121</span></a><a class="elsevierStyleCrossRef" href="#bib1345"><span class="elsevierStyleSup">122</span></a><a class="elsevierStyleCrossRefs" href="#bib1350"><span class="elsevierStyleSup">123,124</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Propionibacterium, freudenreichii</span> subsp. <span class="elsevierStyleItalic">Shermanii</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Liver cancer \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">↓ Significantly in concentration of urinary AFB-N<span class="elsevierStyleSup">7</span>-guanine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib1360"><span class="elsevierStyleSup">125</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Lactobacillus reuteri</span> PTCC 1655, <span class="elsevierStyleItalic">Lactobacillus kefiri</span> P-IF \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Gastric cancer \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Inhibits cell proliferation↑ Apoptosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib1365"><span class="elsevierStyleSup">126</span></a><a class="elsevierStyleCrossRef" href="#bib1370"><span class="elsevierStyleSup">127</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Lactobacillus acidophilus</span>, <span class="elsevierStyleItalic">Bifidobacterium bifidum</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cervical cancer \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">↓ Incidence of radiation-induced diarrhea \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib1375"><span class="elsevierStyleSup">128</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Clostridium butyricum</span> MIYAIRI 588 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Non-small cell lung cancer \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">↓ Intestinal epithelial damage, Improve immune checkpoint blockade \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRefs" href="#bib1235"><span class="elsevierStyleSup">100,129</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">6. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Enterococcus faecium 12a</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cervical cancer, lung cancer \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Inhibit proliferation of cancer cells \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib1385"><span class="elsevierStyleSup">130</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Enterococcus thailandicus</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Liver cancer \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Inhibition of hepatocellular carcinoma cell growth \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib1390"><span class="elsevierStyleSup">131</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">8. \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Enterococcus mundtii C4L10</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Breast cancer, lung cancer and colon cancer \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Apoptogenic, antimicrobial, and antiproliferative properties \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><a class="elsevierStyleCrossRef" href="#bib1395"><span class="elsevierStyleSup">132</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab3710928.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">The role of probiotics in different cancer types and the involved mechanisms.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:147 [ 0 => array:3 [ "identificador" => "bib0740" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Role of lung and gut microbiota on lung cancer pathogenesis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00432-021-03644-0" "Revista" => array:6 [ "tituloSerie" => "J Cancer Res Clin Oncol" "fecha" => "2021" "volumen" => "147" "paginaInicial" => "2177" "paginaFinal" => "2186" "link" => array:1 [ …1] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0745" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gender disparities in lung cancer survival from an enriched Florida population-based cancer registry" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amsu.2020.11.081" "Revista" => array:6 [ "tituloSerie" => "Ann Med Surg (Lond)" "fecha" => "2020" "volumen" => "60" "paginaInicial" => "680" "paginaFinal" => "685" "link" => array:1 [ …1] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0750" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systems biology approaches to develop innovative strategies for lung cancer therapy" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/cddis.2014.28" "Revista" => array:5 [ "tituloSerie" => "Cell Death Dis" "fecha" => "2014" "volumen" => "5" "paginaInicial" => "e1260" "link" => array:1 [ …1] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0755" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk factors of lung cancer in nonsmoker" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.currproblcancer.2017.07.002" "Revista" => array:6 [ "tituloSerie" => "Curr Probl Cancer" "fecha" => "2017" "volumen" => "41" "paginaInicial" => "328" "paginaFinal" => "339" "link" => array:1 [ …1] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0760" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anticancer and anti-inflammatory activity of probiotic <span class="elsevierStyleItalic">Lactococcus lactis</span> NK34" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4014/jmb.1503.03033" "Revista" => array:6 [ "tituloSerie" => "J Microbiol Biotechnol" "fecha" => "2015" "volumen" => "25" "paginaInicial" => "1697" "paginaFinal" => "1701" "link" => array:1 [ …1] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0765" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Probiotic potential of Lactobacillus strains with anti-allergic effects from kimchi for yogurt starters" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "LWT – Food Sci Technol" "fecha" => "2014" "volumen" => "58" "paginaInicial" => "130" "paginaFinal" => "134" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0770" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.canlet.2013.08.013" "Revista" => array:6 [ "tituloSerie" => "Cancer Lett" "fecha" => "2014" "volumen" => "345" "paginaInicial" => "258" "paginaFinal" => "270" "link" => array:1 [ …1] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0775" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Microorganisms with claimed probiotic properties: an overview of recent literature" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/ijerph110504745" "Revista" => array:6 [ "tituloSerie" => "Int J Environ Res Public Health" "fecha" => "2014" "volumen" => "11" "paginaInicial" => "4745" "paginaFinal" => "4767" "link" => array:1 [ …1] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0780" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0785" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interactions between the microbiota and the immune system" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.1223490" "Revista" => array:6 [ …6] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0790" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Probiotics and lung diseases" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1378/chest.10-1861" "Revista" => array:6 [ …6] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0795" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The microbiome and the respiratory tract" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1146/annurev-physiol-021115-105238" "Revista" => array:6 [ …6] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0800" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The gut–lung axis in health and respiratory diseases: a place for inter-organ and inter-kingdom crosstalks" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3389/fcimb.2020.00009" "Revista" => array:5 [ …5] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0805" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The future of mucosal immunology: studying an integrated system-wide organ" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ni0710-558" "Revista" => array:6 [ …6] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0810" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Desired turbulence? Gut–lung axis, immunity, and lung cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1155/2017/5035371" "Revista" => array:5 [ …5] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0815" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of diet on gut microbiota composition" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0820" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diversity in gut bacterial community of school-age children in Asia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/srep08397" "Revista" => array:5 [ …5] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0825" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The influence of lung microbiota on lung carcinogenesis, immunity, and immunotherapy" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.trecan.2019.12.007" "Revista" => array:6 [ …6] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0830" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diet, microbiota and gut–lung connection" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3389/fmicb.2018.02147" "Revista" => array:5 [ …5] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0835" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cross-talk between antigen presenting cells and T cells impacts intestinal homeostasis, bacterial infections, and tumorigenesis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3389/fimmu.2019.00360" "Revista" => array:5 [ …5] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0840" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1155/2015/931574" "Revista" => array:5 [ …5] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0845" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Microbes, metabolites, and the gut–lung axis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/s41385-019-0160-6" "Revista" => array:6 [ …6] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0850" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The microbiota protects against respiratory infection via GM-CSF signaling" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/s41467-017-01803-x" "Revista" => array:5 [ …5] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0855" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mechanisms of methicillin-resistant <span class="elsevierStyleItalic">Staphylococcus aureus</span> pneumonia-induced intestinal epithelial apoptosis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/SHK.0b013e318259abdb" "Revista" => array:6 [ …6] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0860" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium “The Intelligent Intestine,” held in Paris, June 14, 2002" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ajcn/78.4.675" "Revista" => array:6 [ …6] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0865" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Normalization of host intestinal mucus layers requires long-term microbial colonization" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.chom.2015.10.007" "Revista" => array:6 [ …6] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0870" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1146/annurev-pathol-011110-130318" "Revista" => array:6 [ …6] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0875" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/mi.2011.41" "Revista" => array:6 [ …6] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0880" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "How the intricate interaction among toll-like receptors, microbiota, and intestinal immunity can influence gastrointestinal pathology" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1155/2015/489821" "Revista" => array:5 [ …5] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0885" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Stool microbiota and vaccine responses of infants" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1542/peds.2013-3937" "Revista" => array:6 [ …6] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0890" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Development and survival of Th17 cells within the intestines: the influence of microbiome- and diet-derived signals" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4049/jimmunol.1401835" "Revista" => array:6 [ …6] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0895" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "IL-17 in lung disease: friend or foe?" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/thoraxjnl-2013-203307" "Revista" => array:6 [ …6] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0900" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sarcoidosis is a Th1/Th17 multisystem disorder" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/thx.2010.140319" "Revista" => array:6 [ …6] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0905" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The Th17 pathway in cystic fibrosis lung disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.201102-0236OC" "Revista" => array:6 [ …6] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0910" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1600-6143.2008.02321.x" "Revista" => array:6 [ …6] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0915" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lung microbiota promotes tolerance to allergens in neonates via PD-L1" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nm.3568" "Revista" => array:6 [ …6] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0920" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Commensal microbiota promote lung cancer development via γδ T cells" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cell.2018.12.040" "Revista" => array:6 [ …6] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0925" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nmicrobiol.2016.31" "Revista" => array:5 [ …5] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0930" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.1240527" "Revista" => array:6 [ …6] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0935" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The microbial metabolite desaminotyrosine protects from influenza through type I interferon" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.aam5336" "Revista" => array:6 [ …6] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0940" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Microbiota regulates immune defense against respiratory tract influenza A virus infection" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1073/pnas.1019378108" "Revista" => array:6 [ …6] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0945" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Miscanthus<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>giganteus stem versus leaf-derived lignins differing in monolignol ratio and linkage" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/ijms20051200" "Revista" => array:5 [ …5] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0950" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bile acids drive the newborn's gut microbiota maturation" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/s41467-020-17183-8" "Revista" => array:5 [ …5] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0955" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interactions between the intestinal microbiota and bile acids in gallstones patients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/1758-2229.12319" "Revista" => array:6 [ …6] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0960" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intestinal bacteria metabolize the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine following consumption of a single cooked chicken meal in humans" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.fct.2007.07.008" "Revista" => array:6 [ …6] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib0965" "etiqueta" => "46" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interplay between the human gut microbiome and host metabolism" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/s41467-019-12476-z" "Revista" => array:5 [ …5] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib0970" "etiqueta" => "47" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Targeting cancer metabolism: a therapeutic window opens" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nrd3504" "Revista" => array:6 [ …6] ] ] ] ] ] 47 => array:3 [ "identificador" => "bib0975" "etiqueta" => "48" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The lung microbiome: a central mediator of host inflammation and metabolism in lung cancer patients?" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/cancers13010013" "Revista" => array:5 [ …5] ] ] ] ] ] 48 => array:3 [ "identificador" => "bib0980" "etiqueta" => "49" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "“Reinforcement” by tumor microenvironment: the seventh “R” of radiobiology" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 49 => array:3 [ "identificador" => "bib0985" "etiqueta" => "50" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Correlation of the lung microbiota with metabolic profiles in bronchoalveolar lavage fluid in HIV infection" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s40168-016-0147-4" "Revista" => array:5 [ …5] ] ] ] ] ] 50 => array:3 [ "identificador" => "bib0990" "etiqueta" => "51" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tracking polymicrobial metabolism in cystic fibrosis airways: <span class="elsevierStyleItalic">Pseudomonas aeruginosa</span> metabolism and physiology are influenced by <span class="elsevierStyleItalic">Rothia mucilaginosa</span>-derived metabolites" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/mSphere.00151-18" "Revista" => array:6 [ …6] ] ] ] ] ] 51 => array:3 [ "identificador" => "bib0995" "etiqueta" => "52" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intestinal microbiota of mice influences resistance to <span class="elsevierStyleItalic">Staphylococcus aureus</span> pneumonia" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/IAI.00037-15" "Revista" => array:6 [ …6] ] ] ] ] ] 52 => array:3 [ "identificador" => "bib1000" "etiqueta" => "53" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gut microbiota in lung cancer: where do we stand?" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/ijms221910429" "Revista" => array:5 [ …5] ] ] ] ] ] 53 => array:3 [ "identificador" => "bib1005" "etiqueta" => "54" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The dynamic lung microbiome in health and disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/s41579-022-00821-x" "Revista" => array:6 [ …6] ] ] ] ] ] 54 => array:3 [ "identificador" => "bib1010" "etiqueta" => "55" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of the bacterial microbiome in lung disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1586/ers.13.24" "Revista" => array:6 [ …6] ] ] ] ] ] 55 => array:3 [ "identificador" => "bib1015" "etiqueta" => "56" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The lung microbiome and viral-induced exacerbations of chronic obstructive pulmonary disease: new observations, novel approaches" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.201309-1573ED" "Revista" => array:6 [ …6] ] ] ] ] ] 56 => array:3 [ "identificador" => "bib1020" "etiqueta" => "57" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The gut microbiome as a biomarker of cancer progression among female never-smokers with lung adenocarcinoma" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.21873/anticanres.15633" "Revista" => array:6 [ …6] ] ] ] ] ] 57 => array:3 [ "identificador" => "bib1025" "etiqueta" => "58" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Role of the microbiota in lung cancer: insights on prevention and treatment" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/ijms23116138" "Revista" => array:5 [ …5] ] ] ] ] ] 58 => array:3 [ "identificador" => "bib1030" "etiqueta" => "59" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The impact of the intestinal microbiota in therapeutic responses against cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.crvi.2018.03.004" "Revista" => array:6 [ …6] ] ] ] ] ] 59 => array:3 [ "identificador" => "bib1035" "etiqueta" => "60" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of gut microbiota on LPS-induced acute lung injury by regulating the TLR4/NF-kB signaling pathway" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.intimp.2020.107272" "Revista" => array:5 [ …5] ] ] ] ] ] 60 => array:3 [ "identificador" => "bib1040" "etiqueta" => "61" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Role of the microbiota in immunity and inflammation" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cell.2014.03.011" "Revista" => array:6 [ …6] ] ] ] ] ] 61 => array:3 [ "identificador" => "bib1045" "etiqueta" => "62" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Advanced proteomics as a powerful tool for studying toxins of human bacterial pathogens" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/toxins11100576" "Revista" => array:5 [ …5] ] ] ] ] ] 62 => array:3 [ "identificador" => "bib1050" "etiqueta" => "63" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fighting cancer with bacteria and their toxins" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/ijms222312980" "Revista" => array:5 [ …5] ] ] ] ] ] 63 => array:3 [ "identificador" => "bib1055" "etiqueta" => "64" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Specific gut microbiome signature predicts the early-stage lung cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/19490976.2020.1737487" "Revista" => array:6 [ …6] ] ] ] ] ] 64 => array:3 [ "identificador" => "bib1060" "etiqueta" => "65" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alterations of the human gut microbiome in liver cirrhosis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nature13568" "Revista" => array:6 [ …6] ] ] ] ] ] 65 => array:3 [ "identificador" => "bib1065" "etiqueta" => "66" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alterations of the human lung and gut microbiomes in non-small cell lung carcinomas and distant metastasis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/Spectrum.00802-21" "Revista" => array:5 [ …5] ] ] ] ] ] 66 => array:3 [ "identificador" => "bib1070" "etiqueta" => "67" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nm.3444" "Revista" => array:6 [ …6] ] ] ] ] ] 67 => array:3 [ "identificador" => "bib1075" "etiqueta" => "68" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lung and gut microbiota as potential hidden driver of immunotherapy efficacy in lung cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ …4] ] ] ] ] ] 68 => array:3 [ "identificador" => "bib1080" "etiqueta" => "69" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interaction between the microbiome and TP53 in human lung cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s13059-018-1501-6" "Revista" => array:5 [ …5] ] ] ] ] ] 69 => array:3 [ "identificador" => "bib1085" "etiqueta" => "70" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The lung microbiota and lung cancer: a growing relationship" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/cancers14194813" "Revista" => array:5 [ …5] ] ] ] ] ] 70 => array:3 [ "identificador" => "bib1090" "etiqueta" => "71" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Microbiota in cancer: molecular mechanisms and therapeutic interventions" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ …4] ] ] ] ] ] 71 => array:3 [ "identificador" => "bib1095" "etiqueta" => "72" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.201710-2118OC" "Revista" => array:6 [ …6] ] ] ] ] ] 72 => array:3 [ "identificador" => "bib1100" "etiqueta" => "73" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Airway PI3K pathway activation is an early and reversible event in lung cancer development" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ …4] ] ] ] ] ] 73 => array:3 [ "identificador" => "bib1105" "etiqueta" => "74" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ijc.31098" "Revista" => array:6 [ …6] ] ] ] ] ] 74 => array:3 [ "identificador" => "bib1110" "etiqueta" => "75" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The microbiota of breast tissue and its association with breast cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/AEM.01235-16" "Revista" => array:6 [ …6] ] ] ] ] ] 75 => array:3 [ "identificador" => "bib1115" "etiqueta" => "76" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.21037/tlcr-20-156" "Revista" => array:6 [ …6] ] ] ] ] ] 76 => array:3 [ "identificador" => "bib1120" "etiqueta" => "77" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "PARP1 is up-regulated in non-small cell lung cancer tissues in the presence of the cyanobacterial toxin microcystin" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3389/fmicb.2018.01757" "Revista" => array:5 [ …5] ] ] ] ] ] 77 => array:3 [ "identificador" => "bib1125" "etiqueta" => "78" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Apoptotic effects of the b subunit of bacterial cytolethal distending toxin on the A549 lung cancer cell line" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.7314/apjcp.2016.17.s3.299" "Revista" => array:7 [ …7] ] ] ] ] ] 78 => array:3 [ "identificador" => "bib1130" "etiqueta" => "79" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Modulation of cancer signaling pathways by probiotics: implications for therapeutic potential" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 79 => array:3 [ "identificador" => "bib1135" "etiqueta" => "80" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of short-chain fatty acids in cancer prevention and therapy" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ …4] ] ] ] ] ] 80 => array:3 [ "identificador" => "bib1140" "etiqueta" => "81" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Probiotic modulation of the immune response in lung cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 81 => array:3 [ "identificador" => "bib1145" "etiqueta" => "82" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Using probiotics to modulate tumor progression in lung cancer: a review of experimental models" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 82 => array:3 [ "identificador" => "bib1150" "etiqueta" => "83" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lung microbiome and cancer: implications for cancer therapy" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 83 => array:3 [ "identificador" => "bib1155" "etiqueta" => "84" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3389/fimmu.2021.578386" "Revista" => array:5 [ …5] ] ] ] ] ] 84 => array:3 [ "identificador" => "bib1160" "etiqueta" => "85" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Probiotics in cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3389/fonc.2021.638148" "Revista" => array:5 [ …5] ] ] ] ] ] 85 => array:3 [ "identificador" => "bib1165" "etiqueta" => "86" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3389/fimmu.2019.00277" "Revista" => array:5 [ …5] ] ] ] ] ] 86 => array:3 [ "identificador" => "bib1170" "etiqueta" => "87" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Historic perspective: prebiotics, probiotics, and other alternatives to antibiotics" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3382/ps.2010-01030" "Revista" => array:6 [ …6] ] ] ] ] ] 87 => array:3 [ "identificador" => "bib1175" "etiqueta" => "88" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of the gut microbiota, prebiotics, and probiotics on human health and disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4103/2319-4170.138314" "Revista" => array:6 [ …6] ] ] ] ] ] 88 => array:3 [ "identificador" => "bib1180" "etiqueta" => "89" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Stress responses of lactic acid bacteria" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:2 [ …2] ] ] ] ] ] 89 => array:3 [ "identificador" => "bib1185" "etiqueta" => "90" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Personal reflections on the origins and emergence of recombinant DNA technology" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1534/genetics.109.112144" "Revista" => array:6 [ …6] ] ] ] ] ] 90 => array:3 [ "identificador" => "bib1190" "etiqueta" => "91" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nonpathogenic <span class="elsevierStyleItalic">Escherichia coli</span> strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/IAI.01193-07" "Revista" => array:6 [ …6] ] ] ] ] ] 91 => array:3 [ "identificador" => "bib1195" "etiqueta" => "92" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The gut microbiota influences anticancer immunosurveillance and general health" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/s41571-018-0006-2" "Revista" => array:6 [ …6] ] ] ] ] ] 92 => array:3 [ "identificador" => "bib1200" "etiqueta" => "93" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The bacterium <span class="elsevierStyleItalic">Akkermansia muciniphila</span>: a sentinel for gut permeability and its relevance to HIV-related inflammation" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3389/fimmu.2020.00645" "Revista" => array:5 [ …5] ] ] ] ] ] 93 => array:3 [ "identificador" => "bib1205" "etiqueta" => "94" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lung cancer immunotherapy: progress, pitfalls, and promises" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ …4] ] ] ] ] ] 94 => array:3 [ "identificador" => "bib1210" "etiqueta" => "95" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Is mitochondrial metabolism a new predictive biomarker for antiprogrammed cell death protein-1 immunotherapy?" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1200/OP.22.00733" "Revista" => array:6 [ …6] ] ] ] ] ] 95 => array:3 [ "identificador" => "bib1215" "etiqueta" => "96" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/1759-7714.13442" "Revista" => array:6 [ …6] ] ] ] ] ] 96 => array:3 [ "identificador" => "bib1220" "etiqueta" => "97" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Probiotics mechanism of action on immune cells and beneficial effects on human health" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/cells12010184" "Revista" => array:5 [ …5] ] ] ] ] ] 97 => array:3 [ "identificador" => "bib1225" "etiqueta" => "98" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mitochondrial metabolism: a new dimension of personalized oncology" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/cancers15164058" "Revista" => array:5 [ …5] ] ] ] ] ] 98 => array:3 [ "identificador" => "bib1230" "etiqueta" => "99" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.aan4236" "Revista" => array:6 [ …6] ] ] ] ] ] 99 => array:3 [ "identificador" => "bib1235" "etiqueta" => "100" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association of probiotic <span class="elsevierStyleItalic">Clostridium butyricum</span> therapy with survival and response to immune checkpoint blockade in patients with lung cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1158/2326-6066.CIR-20-0051" "Revista" => array:6 [ …6] ] ] ] ] ] 100 => array:3 [ "identificador" => "bib1240" "etiqueta" => "101" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4238/2015.May.25.16" "Revista" => array:6 [ …6] ] ] ] ] ] 101 => array:3 [ "identificador" => "bib1245" "etiqueta" => "102" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "<span class="elsevierStyleItalic">Enterococcus hirae</span> and <span class="elsevierStyleItalic">Barnesiella intestinihominis</span> facilitate cyclophosphamide-induced therapeutic immunomodulatory effects" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.immuni.2016.09.009" "Revista" => array:6 [ …6] ] ] ] ] ] 102 => array:3 [ "identificador" => "bib1250" "etiqueta" => "103" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anticancer effects of the microbiome and its products" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nrmicro.2017.44" "Revista" => array:6 [ …6] ] ] ] ] ] 103 => array:3 [ "identificador" => "bib1255" "etiqueta" => "104" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anti-tumour activity of <span class="elsevierStyleItalic">Lactobacillus casei</span> on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigs" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/BF00199768" "Revista" => array:6 [ …6] ] ] ] ] ] 104 => array:3 [ "identificador" => "bib1260" "etiqueta" => "105" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The tumor suppressor function of LECT2 in human hepatocellular carcinoma makes it a potential therapeutic target" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/cgt.2011.5" "Revista" => array:6 [ …6] ] ] ] ] ] 105 => array:3 [ "identificador" => "bib1265" "etiqueta" => "106" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inhibitory effect of <span class="elsevierStyleItalic">Bifidobacterium infantis</span>-mediated sKDR prokaryotic expression system on angiogenesis and growth of Lewis lung cancer in mice" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1471-2407-12-155" "Revista" => array:5 [ …5] ] ] ] ] ] 106 => array:3 [ "identificador" => "bib1270" "etiqueta" => "107" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Microbiota modulate tumoral immune surveillance in lung through a γδT17 immune cell-dependent mechanism" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1158/0008-5472.CAN-13-2462" "Revista" => array:6 [ …6] ] ] ] ] ] 107 => array:3 [ "identificador" => "bib1275" "etiqueta" => "108" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Randomized trial on acute toxicities of weekly vs three-weekly cisplatin-based chemoradiation in head and neck cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/cnr2.1425" "Revista" => array:5 [ …5] ] ] ] ] ] 108 => array:3 [ "identificador" => "bib1280" "etiqueta" => "109" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Survival benefit of induction chemotherapy with paclitaxel and carboplatin followed by chemoradiation versus postoperative treatment in locally advanced gastric cancer: a retrospective cohort study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ …3] ] ] ] ] ] 109 => array:3 [ "identificador" => "bib1285" "etiqueta" => "110" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sumac-rose water mouthwash versus benzydamine to prevent radiation-induced oral mucositis in head and neck cancers: a phase II randomized trial" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00432-023-04687-1" "Revista" => array:6 [ …6] ] ] ] ] ] 110 => array:3 [ "identificador" => "bib1290" "etiqueta" => "111" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Decreasing the adverse effects in pelvic radiation therapy: a randomized controlled trial evaluating the use of probiotics" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.adro.2022.101089" "Revista" => array:5 [ …5] ] ] ] ] ] 111 => array:3 [ "identificador" => "bib1295" "etiqueta" => "112" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Elevation of the efficacy of antitumor vaccine prepared on the base of lectines from B. subtilis B-7025 upon its combined application with probiotics in vivo" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 112 => array:3 [ "identificador" => "bib1300" "etiqueta" => "113" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antitumor effect of sFlt-1 gene therapy system mediated by <span class="elsevierStyleItalic">Bifidobacterium infantis</span> on Lewis lung cancer in mice" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/cgt.2011.57" "Revista" => array:6 [ …6] ] ] ] ] ] 113 => array:3 [ "identificador" => "bib1305" "etiqueta" => "114" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/2162402X.2017.1409929" "Revista" => array:5 [ …5] ] ] ] ] ] 114 => array:3 [ "identificador" => "bib1310" "etiqueta" => "115" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multifunctional effect of probiotic <span class="elsevierStyleItalic">Lactococcus lactis</span> KC24 isolated from kimchi" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 115 => array:3 [ "identificador" => "bib1315" "etiqueta" => "116" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.aac4255" "Revista" => array:6 [ …6] ] ] ] ] ] 116 => array:3 [ "identificador" => "bib1320" "etiqueta" => "117" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.aad1329" "Revista" => array:6 [ …6] ] ] ] ] ] 117 => array:3 [ "identificador" => "bib1325" "etiqueta" => "118" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inhibition of growth and metastasis of breast cancer in mice by milk fermented with <span class="elsevierStyleItalic">Lactobacillus casei</span> CRL 431" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/CJI.0000000000000079" "Revista" => array:6 [ …6] ] ] ] ] ] 118 => array:3 [ "identificador" => "bib1330" "etiqueta" => "119" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The antimetastatic and antiangiogenesis effects of kefir water on murine breast cancer cells" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/1534735416642862" "Revista" => array:6 [ …6] ] ] ] ] ] 119 => array:3 [ "identificador" => "bib1335" "etiqueta" => "120" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ajcn/85.2.488" "Revista" => array:6 [ …6] ] ] ] ] ] 120 => array:3 [ "identificador" => "bib1340" "etiqueta" => "121" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Emerging roles of lactic acid bacteria in protection against colorectal cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3748/wjg.v20.i24.7878" "Revista" => array:6 [ …6] ] ] ] ] ] 121 => array:3 [ "identificador" => "bib1345" "etiqueta" => "122" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Functional outcome, quality of life, and efficacy of probiotics in postoperative patients with colorectal cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00595-010-4450-6" "Revista" => array:6 [ …6] ] ] ] ] ] 122 => array:3 [ "identificador" => "bib1350" "etiqueta" => "123" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery – a double-blind study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2036.2010.04492.x" "Revista" => array:6 [ …6] ] ] ] ] ] 123 => array:3 [ "identificador" => "bib1355" "etiqueta" => "124" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/sj.bjc.6603990" "Revista" => array:6 [ …6] ] ] ] ] ] 124 => array:3 [ "identificador" => "bib1360" "etiqueta" => "125" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ajcn/83.5.1199" "Revista" => array:6 [ …6] ] ] ] ] ] 125 => array:3 [ "identificador" => "bib1365" "etiqueta" => "126" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "In vitro activity of probiotic <span class="elsevierStyleItalic">Lactobacillus reuteri</span> against gastric cancer progression by downregulation of urokinase plasminogen activator/urokinase plasminogen activator receptor gene expression" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4103/0973-1482.204897" "Revista" => array:6 [ …6] ] ] ] ] ] 126 => array:3 [ "identificador" => "bib1370" "etiqueta" => "127" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Selective induction of apoptosis in human gastric cancer cells by <span class="elsevierStyleItalic">Lactobacillus kefiri</span> (PFT), a novel kefir product" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3892/or.2015.4180" "Revista" => array:6 [ …6] ] ] ] ] ] 127 => array:3 [ "identificador" => "bib1375" "etiqueta" => "128" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Randomized controlled trial of live <span class="elsevierStyleItalic">Lactobacillus acidophilus</span> plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/1748-717X-5-31" "Revista" => array:5 [ …5] ] ] ] ] ] 128 => array:3 [ "identificador" => "bib1380" "etiqueta" => "129" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gut microbiota interventions with <span class="elsevierStyleItalic">Clostridium butyricum</span> and norfloxacin modulate immune response in experimental autoimmune encephalomyelitis mice" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3389/fimmu.2019.01662" "Revista" => array:5 [ …5] ] ] ] ] ] 129 => array:3 [ "identificador" => "bib1385" "etiqueta" => "130" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anticancer and antimicrobial potential of enterocin 12a from Enterococcus faecium" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s12866-021-02086-5" "Revista" => array:5 [ …5] ] ] ] ] ] 130 => array:3 [ "identificador" => "bib1390" "etiqueta" => "131" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Purification, characterization, identification, and anticancer activity of a circular bacteriocin from <span class="elsevierStyleItalic">Enterococcus thailandicus</span>" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3389/fbioe.2020.00450" "Revista" => array:5 [ …5] ] ] ] ] ] 131 => array:3 [ "identificador" => "bib1395" "etiqueta" => "132" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anti-proliferative activities of purified bacteriocin from enterococcus mundtii strain C4l10 isolated from the caecum of Malaysian non-broiler chicken on cancer cell lines" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 132 => array:3 [ "identificador" => "bib1400" "etiqueta" => "133" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use of probiotics for prevention of radiation-induced diarrhea" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3748/wjg.v13.i6.912" "Revista" => array:6 [ …6] ] ] ] ] ] 133 => array:3 [ "identificador" => "bib1405" "etiqueta" => "134" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of the enteral administration of <span class="elsevierStyleItalic">Bifidobacterium breve</span> on patients undergoing chemotherapy for pediatric malignancies" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00520-009-0711-6" "Revista" => array:6 [ …6] ] ] ] ] ] 134 => array:3 [ "identificador" => "bib1410" "etiqueta" => "135" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effects of probiotics on depressive symptoms in humans: a systematic review" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s12991-017-0138-2" "Revista" => array:5 [ …5] ] ] ] ] ] 135 => array:3 [ "identificador" => "bib1415" "etiqueta" => "136" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "*<span class="elsevierStyleItalic">Lactobacillus rhamnosus</span> GG* supplementation modulates the immune response to respiratory infections in healthy individuals: a randomized, double-blind, placebo-controlled trial" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ …5] ] ] ] ] ] 136 => array:3 [ "identificador" => "bib1420" "etiqueta" => "137" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Estimation of the potential antitumor activity of microencapsulated *<span class="elsevierStyleItalic">Lactobacillus acidophilus</span>* yogurt formulation in the prevention of cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.resmic.2010.03.001" "Revista" => array:6 [ …6] ] ] ] ] ] 137 => array:3 [ "identificador" => "bib1425" "etiqueta" => "138" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Probiotics to adolescents with obesity: effects on inflammation and metabolic syndrome" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MPG.0b013e318263066c" "Revista" => array:6 [ …6] ] ] ] ] ] 138 => array:3 [ "identificador" => "bib1430" "etiqueta" => "139" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.nut.2010.01.006" "Revista" => array:6 [ …6] ] ] ] ] ] 139 => array:3 [ "identificador" => "bib1435" "etiqueta" => "140" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Probiotic prophylaxis in predicted severe acute pancreatitis: a randomized, double-blind, placebo-controlled trial" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(08)60207-X" "Revista" => array:6 [ …6] ] ] ] ] ] 140 => array:3 [ "identificador" => "bib1440" "etiqueta" => "141" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An update on the use and investigation of probiotics in health and disease" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/gutjnl-2012-302504" "Revista" => array:6 [ …6] ] ] ] ] ] 141 => array:3 [ "identificador" => "bib1445" "etiqueta" => "142" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reactive oxygen production induced by the gut microbiota: pharmacotherapeutic implications" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2174/092986712799828283" "Revista" => array:6 [ …6] ] ] ] ] ] 142 => array:3 [ "identificador" => "bib1450" "etiqueta" => "143" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.2012.3507" "Revista" => array:6 [ …6] ] ] ] ] ] 143 => array:3 [ "identificador" => "bib1455" "etiqueta" => "144" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1126/science.aan3706" "Revista" => array:6 [ …6] ] ] ] ] ] 144 => array:3 [ "identificador" => "bib1460" "etiqueta" => "145" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Molecular mechanisms of action of probiotics in the prevention and treatment of colorectal cancer" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/nu11102453" "Revista" => array:5 [ …5] ] ] ] ] ] 145 => array:3 [ "identificador" => "bib1465" "etiqueta" => "146" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/00042737-200104000-00015" "Revista" => array:6 [ …6] ] ] ] ] ] 146 => array:3 [ "identificador" => "bib1470" "etiqueta" => "147" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fecal microbiota transplantation" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ …4] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack786125" "titulo" => "Acknowledgments" "texto" => "<p id="par0205" class="elsevierStylePara elsevierViewall">Sourav Mohanto would like to acknowledge Yenepoya (Deemed to be University), India for providing the research facilities and resources to draft the manuscript.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/03002896/00000060000000S2/v1_202410311119/S0300289624001443/v1_202410311119/en/main.assets" "Apartado" => array:4 [ "identificador" => "93559" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Review Articles" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/03002896/00000060000000S2/v1_202410311119/S0300289624001443/v1_202410311119/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289624001443?idApp=UINPBA00003Z" ]
